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ABSTRACT 
MECHANISMS OF SLOWED FOOT TAP SPEED IN OLDER ADULTS 
MAY 2016 
ERICA HARTMAN, B.S., UNIVERSITY OF DELAWARE 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Jane A. Kent 
 
Rapid repetitive tapping, like the Foot Tap Test (FTT), slows with age, but the underlying 
mechanisms are unknown.  Purpose: 1. Test the hypotheses that greater performance 
variability, increased muscle coactivation, and slowed muscle contractile speeds are 
related to lower foot tap count (FTC) in older adults; 2. Examine the relationship between 
FTC and physical function in older adults, using the advanced Short Physical 
Performance Battery (SPPB-A), usual and 400m brisk walking speed.  Methods: 18 
young (25.0±3.1years, 9F, mean±SD), and 28 older (73.4±4.9, 14F) healthy adults were 
recruited.  The older adults were divided into Higher (HFO) and Lower (LFO) 
Functioning based on the median SPPB-A score.  Participants performed 10s of rapid 
tapping (FTT) while seated with their foot on a force plate. A MATLAB program was 
used to calculate FTC and variability of the intertap-interval (COV-ITI). Contractile 
speed (rates of force development and relaxation, RFD and RFR) of the dorsiflexor 
muscles of the slower leg were determined using voluntary, rapid submaximal (ballistic) 
contractions. Electromyography (EMG) was recorded on the tibialis anterior (TA), soleus 
(Sol), medial and lateral gastrocnemius during the FTT on the slower foot.  Coactivation 
was calculated using correlation analyses to determine agreement of TA and Sol 
activation during the FTT. Results: The LFO had a lower FTC than Young and HFO 
(45.9±7.0taps, 54.4±7.5, 53.1±5.7, respectively; p=0.003), and lower COV-ITI than 
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Young (12.3±5.9%, 20.5±8.1, respectively, p=0.009). No associations were found in the 
older adults between COV-ITI and FTC. The correlation-coefficient of the EMG signals 
was higher in Young than HFO (0.568±0.209, 0.321±0.129) and was negatively related 
to FTC in older adults (r2=0.274, p=0.005).  The LFO had a slower RFD than Young 
during ballistic contractions and FTC was positively related to maximal RFD (r2=0.345, 
p=0.001) and RFR (r2=0.162, p=0.038) during ballistic contractions in older adults.  The 
FTC of the faster foot was related to SPPB-A (r2=0.329, p=0.001), but not 400m or usual 
walking speed in older adults.  Conclusions: Greater muscle coactivation during the FTT 
and slower force development in the dorsiflexor muscles may negatively affect FTC in 
older adults.  In older adults, FTC is related to a composite measure of function.  
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CHAPTER 1 
INTRODUCTION 
During the 7th decade of life, there is usually a decline in physical function 
associated with aging.  The decrease in physical function is due in part to a number of 
changes that occur within the neuromuscular system.  In particular, older adults may 
have: reduced motor unit (MU) number and increased MU size, decreased muscle mass, 
decreased rate of force production and relaxation, decreased ability to fully activate their 
muscles, and increased muscle coactivation.  Individuals with mobility impairments, such 
as those with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS), have even 
greater neuromuscular changes than their healthy counterparts.  Several tests have been 
validated for identifying individuals with declining physical function, including the 400m 
walk and the Short Physical Performance Battery (SPPB) (15, 80).  While these tests are 
informative and commonly used, the Foot Tap Test (FTT), a 10-second test in which the 
participant is asked to tap their foot as quickly as possible, is a novel measure that is 
quicker and easier to administer than these other measures of function.  The FTT is able 
to track changes in central motor control, or the ability to activate and coordinate muscle 
contractions, and upper motorneuron dysfunction in aging and diseased populations, 
along with having the potential to longitudinally track changes in functional ability (28).  
The FTT requires an individual to rapidly activate and deactivate their dorsiflexor 
muscles.  It has been shown that slowed foot tap speed is a predictor for a decline in gait 
speed, particularly in populations with upper motor neuron diseases, such as ALS (27).  
Foot tap speed has also been shown to predict a decline in function with age, with older 
adults having a slower foot tap speed than younger adults, even when both populations 
 
 
2 
 
have comparable normalized muscle strength and rate of force development in the tibialis 
anterior (TA), and ability to activate their TA (29).  It is postulated that slower foot tap 
speed indicates a decline in central function and that it can be used to identify the decline 
in central function earlier than other tests such as the central activation ratio (26, 28).  
The cause of the slower foot tap speed in older adults and those with mobility 
impairments is still unknown.  The slowing of rapid movements in older adults could be 
due to a number or neuromuscular changes, such as a slowed rate of force development 
and relaxation, a higher prevalence of slow twitch muscle fibers, and a greater amount of 
muscle coactivation.  While the first two likely contribute to the slowing of movement 
with age, they are due to changes in the muscle while greater muscle coactivation is due 
to changes in motor control, or the activation and coordination of muscle contractions.  
Since FTS has been shown to be slower in individuals with diseases affecting the central 
nervous system (CNS), it is possible that coactivation will play a larger role in the 
slowing of rapid repetitive movements than peripheral changes due to aging.  
Coactivation has been defined in two ways: 1) the quantity of antagonist muscle 
activation relative to the quantity of agonist muscle activation: 
 CoActM (%) =   % 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎%𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎   Equation 1 
or, 2) the proportion of time that the antagonist is active during agonist activity (CoActT, 
% of ms).  An increase in coactivation with age is believed to be caused by poor motor 
control; for example, coactivations patterns during gait are not the same for affected vs. 
unaffected limbs in individuals who have had a stroke (35).  Coactivation has been shown 
to be highest when performing small, rapid movements (48).  However, coactivation is 
also an adaptation that could help increase stability around the joints (21).  Joint stability 
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is important in older adults for a number of reasons, particularly fall prevention.  Thus, an 
increase in coactivation in the leg muscles could slow the ability to perform rapid 
movements but improve joint stability in older adults, resulting in less falls.  The Specific 
Aims of this study are: 
Aim 1:  Determine whether coactivation of antagonist muscles is a potential cause of the 
slowed foot tap speed in older adults 
 Hypothesis (H) 1.1. Foot tap speed will be faster in young adults than healthy 
older adults, and healthy older adults will have a faster foot tap speed than 
mobility-impaired older adults. 
 H 1.2. CoActM will be longest in mobility impaired older adults, then healthy 
older adults, with young adults having the lowest CoActM. 
 H 1.3. CoActT will be highest in mobility-impaired older adults, then healthy 
older adults, with young adults having the shortest amount of CoActT. 
 H 1.4. CoActM will be indirectly related to foot tap speed in all older adults.  
Aim 2:  Explore the potential effect of coactivation on physical function in older adults. 
 H 2.1. CoActM will be higher during gait in older adults than in young, and will 
be higher in mobility-impaired adults than healthy older adults. 
 H 2.2. CoActM will be indirectly associated with gait speed in older adults. 
 Exploratory analyses of the associations between CoActM and both gait speed 
variability during the 400m walk and Fall Efficacy Score-International score will 
also be performed. 
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Aim 3 (exploratory):  To analyze the underlying movement patterns during 10-s FTTs in 
young, healthy older and impaired older adults and explore how movement patterns 
change during a task where the participant must match a specific speed. 
 3.1 Evaluate, for each group, dynamic variables such as Intertap-Interval (ITI), 
ground reaction force (GRF) and toe excursion for the 10-s FTT.  Evaluate how 
these dynamic variables change throughout the 90-s FTT in each group. 
 3.2 Evaluate these variables under conditions of constrained (slow, moderate, 
fast) Foot Tap Speed (FTS).  Slow will be established as 30% of max FTS from 
the 10-s FTT, moderate as 60% of max FTS, and fast as 100% of max FTS. 
Significance:  This study will further develop and validate the FTT, and will be 
the first to determine whether coactivation contributes to the decline in the ability to 
perform rapid movements with age.  By examining the relationship between FTS and 
coactivation, along with other peripheral and central neuromuscular properties, the cause 
of slowed FTS in older adults may be identified.  To begin to translate these findings to 
“real world” conditions, the relationship between coactivation during gait and concerns 
about falling will be explored in healthy and impaired older adults.  
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CHAPTER 2 
LITERATURE REVIEW 
Introduction 
The number of individuals living past the age of 65 years has increased almost 
20% in the past decade, along with an increase in life expectancy (77).  A large percent of 
these older adults have functional limitations; particularly, 17% of 65-74 year olds and 
28% of 75-84 year olds have difficulty walking (77).  As individuals age, many 
physiological and behavioral changes occur that impact functional ability.  Beyond the 7th 
decade of life, there are noticeable changes in gait, strength, concerns about falling, 
metabolic cost of activity, and physical activity (PA), among others, all of which can 
impact an older adult’s functional ability, particularly their mobility (5, 16, 39, 68, 72).  
Maintenance of mobility is important for a good quality of life, as it allows for continued 
freedom and enables an individual to perform activities of daily living, such as dressing 
and grocery shopping, without assistance (65).  It is therefore imperative that individuals 
with declining function be identified early so appropriate interventions can be 
implemented to slow the detrimental effects of aging.  For our purpose, aging will be 
defined as the changes in cognitive and physical function that occur as we get older.   
The SPPB and 400m walk time are commonly used tests which identify 
individuals with mobility impairments (15, 80).  However, they are more difficult to 
perform in small spaces and have not been used to identify individuals with CNS 
dysfunction. The FTT is another informative test that is potentially an early predictor of a 
decline in function, such as gait speed, and can be used to identify changes within the 
CNS (28, 59).  The FTT requires rapid activation and deactivation of the dorsiflexor 
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muscles, a task that becomes more difficult with age due to the slowing of rapid 
movements, which could be due to changes within the neuromuscular system that occur 
with aging.  In particular, an increase in coactivation with aging may impact older adults’ 
ability to rapidly activate and deactivate their muscles, including the muscles around the 
ankle joint.  Maintenance of function in the dorsiflexor muscles is of particular 
importance in older adults due to the role of dorsiflexion in toe clearance during gait (55).  
Not only is the FTT an easy and informative marker of changes in the CNS with age, and 
it could potentially provide information about muscle recruitment patterns during a task 
requiring rapid repetitive activation and how these recruitment patterns are impacted by 
age, functional limitations, and movement speed. 
This literature review will focus on the FTT, a potential test for predicting a 
decline in function with age and disease.  It will also address the changes that occur in the 
neuromuscular system with aging, particularly the increase in coactivation.  The 
relationship between coactivation and concerns about falling in older adults will also be 
addressed. 
 
Neuromuscular changes with age  
With aging, many neuromuscular changes occur that impact an individual’s 
functional ability.  These changes may include a: 1) decrease in motor unit (MU) number 
accompanied by an increase in MU size, 2) decrease in muscle mass, 3) increase in 
percentage of slow twitch muscle fibers, 4) decrease in ability to fully activate the 
muscle, 5) increase in muscle coactivation, and 6) decrease in rate of force production 
and relaxation.  These neuromuscular changes are linked to a slowing in movement speed 
 
 
7 
 
(28, 72), a higher metabolic cost of activity (20), and lower power and strength (12) in 
older adults, all of which could impact older adults’ ability to function independently.  It 
is important to note that the decline in PA that usually occurs with age may also play a 
role in many of these changes; this problem will be discussed later. 
The neuromuscular changes that occur with aging are due to changes both within 
the nervous system and the muscle itself.  One of the main causes of the neuromuscular 
changes with aging is motor neuron death, which impacts the arrangement of MUs in the 
muscle (43).  A MU is composed of a motor neuron and the muscle fibers it innervates.  
After the death of a motor neuron, some of its muscle fibers are reinnervated by another 
motor neuron, resulting in increased size of the remaining MU (43, 44).  A larger MU 
means that an individual motor neuron is responsible for the innervation of more muscle 
fibers.  Older adults recruit larger MUs when performing tasks, which could impact their 
ability to modulate their movements, resulting in increased difficulty of fine motor tasks 
(44). 
There is also a loss in the number of muscle fibers with aging, suggesting that 
complete reinnervation by motor neurons does not occur (42).  Both Type I and Type II 
muscle fibers are affected by motor neuron death, with a greater prevalence of loss of 
Type II fibers, thereby increasing the percentage of slow twitch fibers in older adults (39, 
41).  The reduction in the size and number of muscle fibers results in a loss of muscle 
mass, or sarcopenia, and a loss in strength, but not necessarily a loss in specific strength, 
which is strength relative to muscle mass (29).   
Changes in the CNS with age can result in poor regulation and incomplete muscle 
activation.  An impairment of voluntary muscle activation means that an individual is not 
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able to fully activate all MUs and potentially has a reduction in maximal discharge rate of 
the motorneuron when performing a maximal voluntary contraction (MVC; (26).  The 
central activation ratio (CAR), or ratio of force produced during an isometric contraction 
relative to a stimulated contraction (isometric MVC/(MVC+superimposed tetanic 
stimulation)), is a measure that can indicate if there is an impairment in an individual’s 
ability to fully activate the muscle (CAR<1; (26, 29).  A lower CAR score is seen in 
individuals who have an impairment of the CNS, and thus, decreased motor control (26), 
but is rarely seen in healthy older adults (29, 79).  A decline in motor control can also 
results in greater coactivation during movement (20, 21, 33, 53, 66), which will be 
discussed in detail later.  Motor unit discharge rate has been shown to decrease with age; 
for instance, older adults have been shown to have a lower MU discharge rate than 
younger adults during maximal and submaximal (50% of MVC) isometric contractions, 
with a greater difference at higher forces (24, 61).   
The maximal rate of force development and half relaxation time (T1/2) are usually 
slower in older muscles than younger ones (6, 31, 49).  A reduced rate of force 
development during a submaximal voluntary contraction relative to a stimulated 
contraction can be indicative of changes in upper motor neuron function, and has been 
shown to be correlated with slower foot tapping (26).  Both of these muscle properties 
can be determined by stimulating the nerve of interest, which removes the voluntary 
component of the contraction (26).  Together, the rate of force development and T1/2 
contribute to contraction duration (time to peak tension + ½ relaxation time), which tends 
to be longer in older adults for the tibialis anterior (TA) and plantar flexor muscles, which 
could impact older adults’ ability to perform rapid contractions (57, 79).  However, aging 
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has less of an impact on contraction duration in the thigh muscles, highlighting the fact 
that muscles are impacted by aging differently (31, 78).  
Muscle groups do not change equally with age, partially because some muscles 
are essential for performing activities of daily living, such as walking, while others are 
used less frequently.  For the purpose of this paper, the focus will be on the ankle 
dorsiflexor muscles, specifically the TA.  It has been shown that there are significantly 
fewer MU in the TA in old (mean age 66 yrs) and very old (mean age 82 yrs) men than in 
young (mean age 27) men.  Additionally, older men had fewer MUs than very old men, 
indicating an aging effect on MU number in the TA (49).  
Studies have shown that there is a decrease in muscle mass with age in the 
dorsiflexors (29, 79), along with a decrease in strength (6, 49, 79), though not necessarily 
specific strength (29, 79).  Age also does not have an impact on voluntary activation of 
the dorsiflexors, meaning older adults can fully activate their TA and they do not have a 
reduced CAR (6, 29, 32).  In the TA, it is unclear whether the rate of force development 
changes with age, with some studies finding a significant difference (6, 32, 49) and others 
not (29), though this difference could be due to varying definitions for rate of force 
development.  Contraction and relaxation durations in the TA have also been reported to 
last longer in older adults (6, 32, 49).   
Some studies have reported a higher amount of muscle coactivation in the 
antagonist muscles during dorsiflexion in older adults during gait (10, 22, 53, 66) and 
postural control tasks (53), while others have found no difference in lower leg 
coactivation during gait with age (32, 64) and during isometric, concentric and eccentric 
contractions (32).  Changes in the TA with age can impact toe clearance in gait, which is 
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a significant risk factor for falls in the elderly (55).  It is therefore important to identify 
changes in the TA’s function, such as the ability to rapidly activate and deactivate it, 
which could be important for catching onself after a lose of balance. 
 
Foot Tap Speed 
The ability to perform rapid movements, such as finger and foot tapping, 
decreases with changes in the neuromuscular system that are associated with aging and 
disease (51, 59).  Rapid finger tapping is used by neurologists to track the progression of 
diseases impacting the upper motor neurons (UMN) by comparing finger tapping speed 
longitudinally, and against a normal population (51).  A rapid FTT is indicative of 
changes in motor control that occur in diseases that affect the CNS (14, 27, 51, 58, 59), 
and with aging (29, 59).  Foot tapping likely requires the rapid recruitment and 
derecruitment of MU (9), and the modulation of the number of MU recruited because it is 
a fine, submaximal, movement.  For the FTT, participants are asked to tap their foot as 
rapidly as possible for 10s, a task which is more difficult for individuals with mobility 
and motor impairments.   
The results of recent studies suggest that the FTT is potentially an informative 
measure of changes within the central motor system.  Foot Tap Speed is lower in 
individuals who have diseases that affect the central motor system such as cervical 
myelopathy (59), multiple sclerosis (58), Parkinsons’(14), and amyotrophic lateral 
sclerosis (ALS) (27, 50, 51).  The FTT is a measure that can be implemented in the 
clinical setting since it requires only a chair and a tap counter, and has already been 
shown to be correlated with results from current clinical tests (27, 50).  In a study by 
 
 
11 
 
Miller et al., physicians were asked to identify the affected leg of individuals who had 
mild weakness in their leg brought on by an UMN disease using the Babinski sign, a 
commonly used neurological test for identifying an abnormality in the plantar reflex 
which is indicative of CNS dysfunction, and the FTT (50).  This study found that the 
physicians were able to identify the affected limb with more accuracy and confidence 
using the FTT than the Babinski sign (50).  In a study of neuromuscular differences in 
individuals with ALS, Kent-Braun et al., found that individuals with an impaired UMN 
function due to ALS, had a reduced ability to perform fine, rapid movements, measured 
using maximal rate of voluntary force rise and FTS (27).  Foot Tap Speed was correlated 
with the Ashworth spasticity score (P=0.02) in the ALS participants, and a 6-month 
follow up showed a significant reduction in FTS in this population (27).  The FTT is 
already in use by neurologists for assessment of the above mentioned diseases, but its 
clinical use in aging populations is still being developed.   
Foot Tap Speed also decreases with age, is strongly correlated with functional 
measures and other predictors of mobility impairment, such as gait speed, and can 
identify individuals at risk for future mobility impairments (28, 59).  Numasawa et al. 
examined FTS in 792 healthy adults ranging in age from 20-83 years old and found that 
FTS and age were moderately negatively correlated (R= -0.369, P<0.0001; (59).  This 
study also found that FTS was strongly correlated with lower extremity motor function, 
as quantified by the modified Japanese Orthopedic Association (59).  Submitted data 
from Kent-Braun et al. examined FTS and walking speed in 9,698 women over the age of 
65 years old, and found that a slower FTS was directly associated with a lower gait speed 
and effectively predicts slower gait speed at a 2 year follow up (28).  Additionally, this 
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study found a correlation between faster FTS and higher physical function, quantified as 
greater PA, greater grip strength, faster completion of 5-chair rises, and balancing longer 
in a tandem stand (28).  While the use of FTT to track changes in aging is relatively new, 
the results of the above studies highlight the potential possibilities of the FTT. 
The cause of the decrease in FTS with age is unknown.  In a study by Kent-Braun 
et al. the properties of the TA were studied extensively in young (25-44 years) and older 
(65-83 years) men and women with comparable PA levels (29).  The groups were 
compared on specific strength, normalized maximal rate of force development (RFD), 
CAR, and FTS.  Normalized maximal RFD, CAR and FTS are all measures that are 
believed to indicate central deficit but only FTS was statistically different between the 
young (47 ±1 tap/10s) and older (34±1 tap/10s) group (29).  This study found that the 
older group had an impaired ability to perform these rapid dynamic contractions, but did 
not have a difference in other properties in the TA (29).  Additionally, it suggests that the 
FTS may be a more sensitive indicator of changes within the CNS than normalized 
maximal RFD and CAR, potentially causing FTS to be an early detection mechanism for 
changes in the CNS.  The above-mentioned study called into question why FTS decreases 
with age, and highlighted the need for additional studies to determine which changes in 
the neuromuscular system with age are the source of this slowing. 
 
Control of rapid movements 
The ability to rapidly tap one’s foot can be impacted by central or peripheral 
changes in the neuromuscular system.  Centrally, MU discharge (i.e., firing) rate and 
rapid modulation of MUs control how quickly the motor neurons can be activated and 
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deactivated (9).  In young adults, MU firing rate is higher and force required to active a 
MU is lower during rapid isometric contractions than when performing ramp isometric 
protocols, with the firing rate of the TA reaching 60-120 Hz during ballistic contractions 
(9).  In a study by Klass et al., the firing rate of MUs in the TA during rapid isometric 
contractions was found to be higher in young adults than older adults (31).  The change in 
firing rate between the MU’s first, second and third discharge was also examined in 
young and older adults, and older adults were found to have a greater decrease in firing 
rate during the successive firings when compared with young adults (31).  Additionally, it 
has been found that older adults have a lower MU force threshold in the TA than younger 
adults while performing isometric contractions (6).  These studies suggest that MU firing 
rate is higher and the force threshold is lower during rapid contractions, and that young 
adults have higher MU firing rates and a higher force threshold than older adults (6, 9, 
31).  While these studies were isometric and the rapid contractions were not isolated vs 
successive, they provide insight into how MU recruitment might change during rapid, 
repetitive contractions in young and older adults.   
Peripherally, the rate of activation and deactivation of the TA is controlled by 
RFD and relaxation time.  In a study by Klass et al., older adults had lower maximal RFD 
and had longer time to peak torque during fast contractions of the TA when compared 
with young adults (31).  Kent-Braun et al. did not find a difference in rate of force 
development during rapid isometric contractions with aging; however this is likely due a 
difference in methodology (29).  This study expressed voluntary rate of force 
development relative to maximal stimulated rate of torque development in order to 
account for peripheral changes in the muscles, thus using rate of force development as a 
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central, not peripheral, measure (29).  If the muscle has a reduced rate of force relaxation, 
it will take longer before the muscle can be activated again. 
In addition to the changes in central and peripheral factors discussed above, 
changes in motor control, such as regulation of antagonist activity (48), could impact the 
ability to perform rapid movements in older adult.   
 
Coactivation 
 Some studies have shown that older adults use greater coactivation than younger 
adults while performing a range of activities.  Coactivation is defined here in two ways: 
1) the quantity of antagonist activation relative to the quantity of agonist activation, or 
CoActM (Equation 1); and 2) the amount of time in which the antagonist is active during 
the agonist activity, (CoActT, ms).  Antagonist activity is not consistent across all muscle 
groups and actions.  Coactivation tends to be higher in individuals with decreased 
postural stability, decreased motor control, and/or greater mobility impairment.   
Older adults tend to use greater coactivation in their legs than young adults.  
Thigh CoActM has been shown to be higher in older adults while they are walking (64, 
66), and climbing up and down stairs (21, 38).  There are inconsistencies in the literature 
with regard to shank coactivation, with some studies finding that CoActM does not differ 
between old and young while walking (10, 64), or when performing isometric, concentric 
or eccentric contractions (32), while others report a difference in CoActM during gait (22, 
53, 66) and static standing (40, 53).  CoActT of the TA and plantar flexors was found to 
be different between young and older adults in studies of gait and stair climbing (10, 22), 
with older adults having a greater overlap in timing of the activation of the TA and 
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gastrocnemius muscles, due to earlier onset and later offset of the gastrocnemius muscles 
(22).  Coactivation could be impacted by gait changes that occur with aging, such as a 
change in muscle recruitment patterns and power during gait (45, 60, 66, 82).  Older 
adults tend to walk slower, take shorter steps, have lower push-off power, and spend 
more time in double limb support (30, 45, 60, 82), with an even greater reduction of these 
parameters seen in older adults with reduced knee and ankle strength (36).  Older adults 
also tend to have a decreased hip and ankle range of motion which could be related to a 
decline in maximal knee strength with age (34).  
Coactivation during rapid movements is an area of research that has not been 
explored extensively.  In a study on coactivation during elbow extension, Mardsen et al. 
found that coactivation was highest while performing small movements at high velocities 
in the elbow extensors (48).  Conversely, Klass et al. found that CoActM was not different 
when performing rapid movements, finding no difference in the amount of antagonist 
soleus activity relative to the TA’s activity when performing fast, isometric dorsiflexion 
contractions in young and older adults (31).  Coactivation has also been shown to 
increase with gait speed in both young and older adults, but this could be due to the 
difference in the tasks being performed (22).  Additionally, a negative correlation has 
been shown between RFD and coactivation in the knee extensors and flexors in older 
adults, suggesting that greater coactivation could reduce the speed of force development 
(62).  It is evident that additional research is needed to understand how coactivation may 
impact rapid movements in young and older adults.  
It is unclear whether an increase in coactivation with age is a beneficial or 
harmful adaption, but more than likely it is both.  Higher coactivation occurs because 
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more antagonist muscle fibers are recruited, which can decrease force output and increase 
the metabolic cost of movement.  Higher antagonist activity might be an adaptation used 
to increase stiffness around the joint and thus an older adults’ stability, or it could be due 
to poor motor control. A full understanding of the consequences of increased coactivation 
with aging remains to be determined. 
With greater antagonist activity, it is likely that more MU are recruited in both the 
agonist and antagonist muscles.   Greater antagonist activity could cause a reduction in 
force capability in older adults (46).  To counter-act this increase in antagonist activity, it 
is possible that more MU in the agonist would be required.  The increase in agonist and 
antagonist muscle activity likely leads to a higher metabolic cost of movement, which has 
been linked to the slowing of gait speed (67).  Previous studies have shown a relationship 
between the increased coactivation in leg muscles in older adults and higher metabolic 
cost of walking (20, 47, 64).   
In contrast to the negative effects of coactivation, increased antagonist activity 
helps to stiffen the joint, an adaptation that increases joint stability in older adults.  
Hortobagyi et al. found that when performing a downward step, CoActM was 96% higher 
in older adults than younger adults, with the vastus lateralis and bicep femoris muscles 
having 140% greater activation, and the TA having 120% greater CoActM than young 
adults (21).  When the relationship between leg stiffness, defined as force production 
divided by leg displacement (N·m-1) and muscle activity was examined, the above study 
found that 50% of the variance in leg stiffness was accounted for by higher muscle 
activity in the older adults (21).  The adaptation of increasing leg stiffness by coactivation 
has also been seen in studies on individuals who have a fear or history of falling, with 
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these individuals having greater muscle coactivation in the lower leg (7, 54).  In a study 
by Marques et al., which compared gait in fallers and non-fallers, the CoActM ratio for 
TA/Lateral Gastrocnemius (GL) was higher in fallers during all phases of gait (47).  
However, it is also possible that the higher coactivation seen in fallers is not an 
adaptation to increase joint stiffness, but rather because they have worse postural control.  
Older adults with who have less physical function during a functional reach task and 
greater sway area during static standing have been shown to have great coactivation in 
the shank than older adults with better postural control (40, 53). 
 
Falls 
Falling is a major concern for older individuals, with about a third of all persons 
over 65 experiencing a fall each year (5).  Many of these falls lead to minor or major 
injuries.  There are many different factors that can lead to a loss in stability in older 
adults.  Fallers, frequently classified as individuals who had fallen, or nearly fallen, 
during the past year, tend to have a lower isometric strength in the ankle muscles (37) and 
rate of torque development in the dorsiflexor muscles (37, 63),   It has been observed that 
fallers have a greater asymmetry in isometric dorsiflexor strength than nonfallers, along 
with during low velocity eccentric dorsiflexion and plantarflexion (63).  Coactivation has 
been shown to be greater in fallers during gait (47) while it has not been shown to be 
different in the knee or ankle muscles during isometric contraction (37).  In addition, a 
delay in ankle dorsiflexion at the beginning of the swing phase during gait has been 
correlated with higher prevalence of falls (25).   
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The Falls Efficacy Scale-International (FES-I) is a 16-question instrument 
designed to query individuals about their fear of falling during both basic and more 
demanding physical and social activities (83).  The FES-I was developed from the Falls 
Efficacy Scale (FES).  The FES has excellent reliability, is correlated with balance and 
gait, and is able to predict future falls and a decline in physical function (75, 83).  The 
FES-I includes questions that are more relevant to individuals with higher functional 
ability, allowing it to discriminate between individuals with a wider range of functional 
abilities (83).  The FES-I also addresses the impact of an individual’s concern about 
falling on their participation in social activity, extending the questionnaire from the FES, 
which only focuses on physical situations and consequences.  In a one-year follow up 
study, the FES-I showed good predictive validity and there was a general increase in 
FES-I score with time, indicating a greater concern of falling with age (8). 
As discussed previously, coactivation is an adaptation that can help to stabilize 
joints.  It has been found that older adults who have a fear or history of falling have 
greater coactivation than their peers who do not fear falling (40, 47, 54).  Marques et al. 
found that older females who had fallen in the past year had a higher coactivation ratio 
for their TA and GL during gait than older females who had not fallen (47).  A study by 
Laughton et al. examined postural sway and coactivation during quiet stance, and found 
that older adults had a higher rate of coactivation, but there was no difference in 
coactivation between fallers and nonfallers, which was possibly due to the already 
increased coactivation with age (40).  It appears that if an individual is more concerned 
about falling, they will try to maintain stability in their joints, which would include 
stiffening the joints by increasing the activity of the muscles around the ankle and knee.   
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Physical activity and function 
The decline in physical function with age greatly impacts the quality of life of 
older adults, because it results in greater disability and a decreased ability to perform 
activities of daily living (17, 65).  A decline in physical function, specifically mobility, is 
also accompanied by an increased likelihood of falling, and the fear of falling can impact 
the individual’s perceived mobility (2).  Lower daily PA has been related to an increase 
in mobility impairments and a decrease in functional ability in older adults (52).  
Individuals who participate in a greater amount, and a higher intensity, of PA tend to 
have a higher gait speed and are less likely to develop sarcopenia (52, 68).  Two common 
functional tests that have been strongly correlated with declining function in older adults 
are the SPPB and gait speed, specifically the 400 m walk.   
The SPPB is a common functional test that scores individuals from 0-12 based on 
their ability to complete specific tasks (15, 16).  The SPPB includes 3 tasks: time to 
complete a 4m walk at a casual walking speed, ability to balance for 10s in 3 positions 
(tandem, semi-tandem, side-by-side stance), and time to complete 5 chair rises (15, 16).  
The SPPB has been correlated with gait speed, and has proven reliable for testing 
functional ability in older adults (15).  The SPPB has also been shown to predict 
morbidity in a 6 year follow up, with morbidity decreasing by 15% for each increase in 
SPPB point at baseline (80).  An advanced version of the SPPB has also been developed 
and allows for the differentiation of individuals who score a 12 on the SPPB, along with 
more individualized scores for participants (70).  The advanced SPPB (SPPB-A) expands 
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on the SPPB, making the tasks slightly longer and more difficult and minimizes the 
ceiling effect. 
Gait speed has been shown to be a reliable indicator of changes in physical 
function and mobility limitations in older adults (16, 72).  Preferred gait speed is 
correlated with survival rate, with individuals who have a lower gait speed having a 
lower survival rate (72).  Preferred gait speed during a short walking task, specifically the 
4m walk during the SPPB, has been shown to predict future mobility impairments (16).  
The 400m walk test is an endurance walk that is performed at a brisk pace. Time for 
completion has been related to current functional ability (13) and mobility limitations at a 
5 year follow up (56).  Time for completion of the 400m walk test is correlated with 
survival 6 years later, with individuals who were unable to complete the test or were in 
the group which took the longest time to complete the test having the highest rate of 
mortality 6 years out (56, 80).  A study by Vestergaard et al. also found that a larger 
coefficient of variation in lap time, taken across 20 laps, was a predictor of morbidity at 
6-year follow up (80).  Additionally, greater stride time variability while walking has 
been correlated with an increased fall risk in older adults (19).  
Foot tap speed has been correlated with gait speed and other functional measures, 
indicating that the FTT is a reliable way of predicting mobility impairments (28, 59).  
Individuals with mobility limitations have been found to have a lower FTS, gait speed 
and SPPB score.  However, unlike the 400m walk test and the SPPB, the FTT does not 
require an individual to be mobile and could potentially be an early indicator of changes 
in the central nervous system (28).  However, the FTT is currently limited because it is 
susceptible to recorder error.  Currently, the FTT is performed by having an individual 
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tap their foot rapidly on the floor while someone counts their taps and tells them when to 
start and stop (27, 59).  However, this method provides a single outcome variable, the 
number of taps.  It is believed that using a force platform to record the force output of 
each tap and motion capture to track the motion of the foot during the task will increase 
counting accuracy and provide additional information about how the task is being 
performed.  Variations on the traditional FTT, such as reducing the rate of tapping, could 
provide insight into how individuals approach the task of repetitive contractions and how 
speed might impact muscle activation.   
 
Summary 
Over the last 100 years, there has been a steady increase in the number of 
individuals living past the age of 65, along with an increase in life expectancy (77).  A 
major concern for these older adults is a decrease in physical function, specifically 
mobility, and an increase in the prevalence of falls with aging (5, 65).  A simple test, such 
as the FTT, could be beneficial for the identification of individuals who are at risk for 
mobility impairment due to aging and changes in the CNS. Slowing of FTS has been 
shown to be related to a decline in motor control with both disease and aging (28, 51, 58, 
59).  However, the cause of the decreased ability to rapidly activate and deactive the 
dorsiflexors is still unknown.  Slowing of muscle properties with age, such as the rate of 
muscle activation and relaxation, could impact FTS.  However, because FTS has been 
shown to be slower in individuals with varying diseases affecting the CNS, it is likely 
more strongly impacted by changes in central control (14, 27, 50, 51, 58, 59).  Changes in 
central control, such as MU recruitment and muscle coactivation, could play a role in the 
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slowing of FTS (29, 31, 48, 62).  Some studies have found that muscle coactivation in the 
lower leg is higher in older adults while walking, preforming postural control tasks, and 
standing still (22, 40, 53, 66).  While the increase in muscle coactivation with age could 
be detrimental due to its correlation with a higher metabolic cost of movement (20, 47, 
64), it has also been shown to increase joint stiffness (7, 21, 54).  Increased joint stiffness 
is believed to be an adaptive mechanism to increase stability in fallers, which is of 
particular importance because about one in three older adults fall each year while walking 
(5).  Further exploration into the cause of slowed FTS with aging could provide new 
insight into the relationship between coactivation and the ability to perform rapid 
repetitive movements.  Additionally, further analysis of the relationship between lower 
leg coactivation and concerns about falling could yield new insight into identifying 
individuals at risk of falls.  
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CHAPTER 3 
METHODS 
Study Participants 
This study will include three groups: young, older and older impaired adults.  
Sixteen individuals between the ages of 21 and 35 years will be recruited for the young 
group, and 32 individuals between 65 and 85 years will be recruited for the older groups.  
Males and females will be recruited equally.  Half of the older participants will have a 
mild-to-moderate mobility impairment, as defined by a SPPB score of 8-10 (15), and will 
be categorized as “older impaired”.  The other half of the older adults will have no 
mobility impairments, as defined by a SPPB score of 12.  Individuals with an SPPB score 
of 11 will still be tested and analyzed post-hoc.  All experimental procedures and consent 
documents were approved by the University of Massachusetts Amherst Institutional 
Review Board. 
The participants will be relatively sedentary, participating in no more than 1 
structured exercise session > 30 minutes’ duration per week.  Individuals will be 
excluded if they are currently taking medicine that may affect their physical function.  
Those who smoke or have stopped smoking within the previous year will be excluded.  
Individuals will be excluded if they have: significant arthritis in the lower extremities, a 
pacemaker, a history of muscle cramps or pain, a history of neurological or 
neuromuscular disease (including peripheral neuropathy), a history of symptoms upon 
exertion (including dyspnea, cramping, and light-headedness), or had a stroke within the 
past year.  Anyone who has peripheral vascular, cardiac, or pulmonary disease will be 
excluded.  Individuals with controlled hypertension or hypercholesterolemia will be 
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allowed to participate, as will those taking statins, sleep aids or antihypertensive 
medications other than beta-blockers.  Individuals must score between an 8-12 on the 
SPPB in order to participate. 
Procedures 
Potential participants will be screened by telephone before the visits are 
scheduled.  Participants will make 2 visits to the Muscle Physiology and Biomechanics 
Labs at the University of Massachusetts (Totman Bldg, Rm 22 and 23).  Visits will be 
scheduled at least 1 but no more than 3 weeks apart.  The first visit will be a Habituation 
Session lasting 80 minutes (Table 9).  The second visit will be the Testing Session, which 
will last approximately 90 minutes (Table 10).  The participant will be asked to wear 
shorts. Standard neutral running shoes (New Balance) will be provided for the participant 
to wear on both visits.  If the participant wears orthotics, they will be allowed to put the 
orthotics in these shoes. 
Visit 1: Habituation Session 
When participants arrive, they will be led from the foyer of the Totman Building to 
the Muscle Physiology Laboratory.  The study will be explained in detail and a researcher 
will review the Informed Consent document with the participant.  If they choose to 
participate, the participant will read and sign the Informed Consent document, which 
satisfies the requirements of the University of Massachusetts Amherst Institutional 
Review Board.  They will then fill out a Medical History Form, a Physical Activity 
Readiness Questionnaire (74), the FES-I questionnaire (83), and the SF-36 (81); 
Appendix). 
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The Medical History Form asks about relevant diseases and medical diagnoses.  
This questionnaire is designed to verify that the participant meets all of the inclusion 
criteria and does not meet any of the exclusion criteria.  The Physical Activity Readiness 
Questionnaire is designed to verify that the participant does not have any restrictions 
during PA, such as light headedness or pain, and that it is safe for them to engage in PA.  
The FES-I asks a series of questions about how concerned an individual is about falling 
in a variety of scenarios including during basic and more demanding activities that are 
both physical and social.  The SF-36 asks about physical and emotional health, and has 
questions designed to address if the individual experiences pain in general. 
After completing the questionnaires, the participant’s resting blood pressure will 
be taken.  At this point they will have been seated quietly for at least 10 min.  Next, the 
participant’s height and weight will be taken using a Detecto-Medic scale (Detecto Scales 
Inc, Brooklyn NY).  The participant’s body mass index (BMI) will be calculated as 
mass/height2 (kg·m-2). 
Physical Activity Assessment 
Each participant will be given a uniaxial accelerometer (model GT1M, Actigraph, 
LLC Pensacola, FL., USA) to objectively record their PA.  They will wear the 
accelerometer on a belt at their waist for 7 consecutive days, which will provide data 
about their activity during the week and weekend.  They will be instructed to wear the 
accelerometer during all waking hours, except when they are in water.  An activity log 
will be used by the participant to record their daily activities, sleep schedule, PA bouts, 
and any illness and activities outside of their normal activity.  They will be instructed to 
maintain as normal a PA pattern as possible.  This accelerometer is unable to record PA 
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from cycling and swimming; therefore participants will be encouraged to record these 
activities in their log carefully and avoid them if they are not part of their normal routine.  
Data will be collected in 60s epochs and used to determine total activity counts and count 
intensity for each day (11).  The PA data will be separated into time spent in low-
intensity PA (1-1951 counts·min-1, ≤3 METS) and moderate-to-vigorous (≥1952 
counts·min-1, >3 METS) based on cutpoints established by Freedson et al. (11).   
Physical Function Measures 
The participant’s functional ability will then be measured using the normal and 
advanced SPPB.  The normal SPPB scores the participant from 0-12 based on their 
ability to complete specific tasks and will be used to separate individuals into groups (15, 
16).  The Advanced SPPB (SPPB-A) is an extended version of the test that allows for 
more precise scoring and distinguishes between individual who receive a 12, reducing the 
ceiling effect of the SPPB (70).  A scoring chart for each test can be found in the 
Appendix.  The chair rise and balance tests will occur in the Biomechanics Lab, and the 
walking test will occur in the hallway outside the Muscle Physiology Lab.   
First, walking speed will be tested with a 6m walk between 2 lines 6 inches apart 
on the floor.  The participant will be instructed to walk at a casual walking speed, as if 
they were walking down the street, with no criterion of staying between the lines.  This 
will be done twice and the faster of the 2 walks will be used for analysis.  Next, they will 
perform the Balance Gait test where they will be instructed to walk between the lines at a 
casual speed.  This will be performed twice and the fastest time will be used.  If they step 
outside the lines twice, they will be given a zero on the SPPB-A. 
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Next, the participant will perform the chair rise test.  They will be led into the 
Biomechanics lab where a chair will be set up just off the force platforms so that when 
they stand up, their feet are on the force platform (AMTI, Advanced Mechanical 
Technology Inc, Watertown MA).  The participant will perform 10 chair rises, which 
involves standing up from a standardized chair 10 times, as quickly as possible.  A split 
time will be taken after 5 chair rises.  Their arms will be crossed over their chest to 
prevent them from being used during the task.   
Balance will then be tested on the force platform for 3 foot positions: tandem, 
semi-tandem, and side-by-side stance.  The participant will be allowed to hold the 
researcher’s arm as they are getting into each position.  Once they are ready, they will 
release their grip and try to hold the foot position for as long as possible, for up to 30s.  
The time will be stopped if they move their foot from the position or grasp onto the 
researcher’s arm.  Testing will begin with the side-by-side stance, where the feet are next 
to each other.  Next the participant will perform the semi-tandem stance, where the heel 
of one foot is placed next to the big toe of the other foot. They will then be tested using 
the full tandem stance, one foot directly in front of the other, for up to 30s.  The 
participant will then stand on one leg for up to 30s, and they will be able to pick which 
leg they prefer. 
Familiarization 
Next, the participant will be introduced to the equipment that will be used during 
the Testing Session.  In the Biomechanics Lab they will be familiarized with the Humac 
Norm dynamometer (CSMi, Stoughton MA).  They will lay on the Humac with their leg 
fully extended and their thigh and torso strapped to the chair to prevent movement.  The 
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foot that will be tested will be strapped to the force transducer plate, and their free leg 
will rest comfortably on a bar.  The participant will practice plantar and dorsiflexion 
isometric MVCs.  Once they have been familiarized with the MVC protocol, the 
participant will then be taken to the foot-tapping station, where they will sit comfortably 
in a chair with the ball of one foot resting on an AMTI force platform.  The participant 
will be instructed on how to tap their foot (lifting the ball of the foot off the ground and 
putting it back down as fast as possible).  The participant will practice rapidly tapping 
each foot for several seconds; this will be done 3-4 times for each foot.  They will then 
perform 2 10-s FTT on each foot, alternating between legs, during which time the force 
platform will record the GRF.  The slower leg, as defined by a slower FTS by manual 
analysis of the force data, will be used for further analysis.   
Stimulated Force Production 
In the Muscle Physiology Lab, a stimulating electrode will be placed on the 
peroneal nerve, which is about 1 cm distal to the fibular head, of the leg being tested in 
order to stimulate the TA.  Surface electromyography (EMG) electrodes will be used to 
measure muscle activation.  A gold-plated disk electrodes (10 mm) for recording EMG 
will be placed on the muscle belly of the TA, while another is placed on the distal tendon 
of the TA and will be used as a ground.  A copper ground plate (6x6 cm) will be placed 
half way between the stimulating and EMG electrode to reduce stimulation artifact.  The 
participant will be seated with their hip at ~180°, knee at ~120° of knee extension, and 
ankle at 10° of plantar flexion.  Their foot will be securely strapped to a custom designed 
platform attached to a force transducer which is used to measure dorsiflexion and plantar 
flexion force.  The stimulating electrode will be attached to a stimulator (model DS7, 
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Digitimer Stimulator, Hertfordshire, UK).  All stimuli and EMG recordings will be 
obtained using LabView software (National Instruments, Austin TX).  The stimulation 
intensity will be determined through single twitch stimuli with increasing current until 
additional current yield no increase in compound muscle action potential (CMAP).  A 
current set at 115% of the current needed to elicit a maximal CMAP will be used for 
testing.  The participant will be told to relax their muscle and three baseline twitches will 
be administered with at least 30s in between each of them.  The participant will then be 
asked to perform 3 isometric dorsiflexion MVCs lasting 3-5s, with a minute rest in 
between.  During the last MVC, a tetanic train (50 Hz, 0.50s) will be administer when 
force is at a plateau in order to calculate CAR.  Next, the participant will perform a rapid 
contraction with the instruction to reach 40% of peak MVC torque as quickly as possible, 
then to relax.  A light diode will inform the participant of the percent of their MVC.  
They will practice this test until they can reach 40% reliably then perform the test 3 
times, with a 30s break in between.  A twitch stimulation and a train stimulation (50 Hz, 
0.5s) will then be applied while they are relaxed.    
Visit 2: Testing Session 
At the start of Visit 2, we will collect the activity log and accelerometer and the 
participant will then be taken into the Biomechanics Lab where testing will occur.  The 
protocol will be reviewed with the participant.  The participant will warm up by pedaling 
lightly on a recumbent cycle ergometer (Schwinn, Nautilus, Inc., Vancouver, 
Washington) for 5 minutes, followed by light stretching of the lower extremity muscles, 
focusing on the calf and TA. 
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EMG Electrode Application 
Wireless surface electromyography (EMG) electrodes (Trigno, Delsys Inc, Natick 
MA, USA) will then be placed on the belly of the tibilias anterior (TA), medial 
gastrocnemius (GM), lateral gastrocnemius (GL), and soleus (SO) muscles of the chosen 
leg, using the “Surface Electromyography for Non-Invasive Assessment of Muscles” 
guidelines for EMG sensor placement (73).  The locations for the GM, GL and SO 
electrodes will be identified by asking the participant to stand on their toes, while using a 
table to support their weight.  The location for the TA will be identified by asking the 
participant to dorsiflex against manual resistance.  Once the electrode locations have been 
determined and marked with a sharpie, a 5x3 cm rectangle will be shaved over each 
muscle belly.  An alcohol swab will be used to clean the skin and the EMG electrodes 
will be adhered to the skin.  After the EMG electrodes have been placed on the muscle, 
the electrode signal quality will be tested by asking the participant to again stand on their 
toes and then to dorsiflex.  If necessary, the electrodes will be moved to achieve a better 
signal-to-noise ratio, which will be determined by visual inspection, using the Delsys 
display, of the difference between the amplitude at the baseline and when the muscle is 
contracting.  Once a clear signal is achieved, pre-tape wrap will be wrapped around the 
leg and electrodes to further secure the electrodes in place.   
Muscle Strength Tests 
After placement of the EMG electrodes, the participant will be positioned on the 
Humac Norm dynamometer to test muscle strength and record EMG activity during 
MVCs.  The participant will lie on the flat Humac chair as described previously, with the 
testing leg fully extended.  The leg not being tested will rest comfortably on a bar 
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extending from the chair.  The participant’s foot will be strapped onto the force 
transducer plate, which will be at 10° of plantar flexion.  The thigh and torso will be 
strapped securely to the Humac to prevent movement, and pads will be placed under the 
knee for support. 
After the participant is positioned on the Humac, the plantar and dorsiflexion 
protocols will be reviewed.  The participant will be instructed not to use their knee or hip 
to perform the contractions.  They will have 2 practice trials of plantar flexion, during 
which their torque profile will be visible on the computer.  The participant will be 
instructed to contract as fast and hard as possible and hold the MVC for 3-5s, with the 
goal of having the torque rise quickly and remain level during the MVC.  After these 2 
practice trials, the participant will perform 3 plantar flexion MVCs.  Verbal 
encouragement will be provided during the 3 MVCs, and the participant will be 
instructed to push the ball of their foot down as hard as possible, as if they were hitting 
the gas pedal of a car.  Each MVC will last for 3-5s, and the participant will be given 90s 
of rest between each trial, to prevent fatigue.  Following the plantar flexion protocol, the 
procedure will be repeated for dorsiflexion, with the participant having 2 practice trials 
followed by 3 test trials.  The participant will be instructed to pull their foot up, as if 
lifting their foot off the gas, as fast and as hard as possible. 
Foot Tap Tests  
The participant will rest for 3 min after the MVCs, during which time motion 
capture makers will be placed on the leg being studied.  The motion capture markers are 
retro-reflective spheres of 2 cm diameter that will be placed on anatomical landmarks (5th 
metatarsal, medial and lateral malleolus, tibial tuberosity, 1st toe), along with a cluster of 
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markers on the heel.  The markers will be used to track the motion of the foot during the 
FTT.  Next, the participant will stand in the anatomical position in the center of the 
motion capture collection area on the middle force platform and a 5s static calibration 
will be taken.  The collection area has 11 Qualysis motion capture cameras (Qualisys, 
Gothenburg, Sweden), which will collect data at a sampling rate of 200 Hz. 
For the foot tap tests, the participant will sit in a standard chair centered in the 
calibrated volume of the motion capture area, about 15 cm behind the force platform, 
which is a 60 cm by 120 cm rectangle (Figure 10).  The participant will be instructed to 
sit comfortably with the middle and ball of their foot on the force platform, but the heel 
resting off the platform.  When the participant lifts the ball of their foot during the 
tapping task, no part of their shoe should be in contact with the force platform.  The 
participant will be seated with their knee, ankle and hip each at approximately 90° of 
flexion.  Tape will put on the platform along the edge or top of the participant’s foot as a 
visual guideline for the foot’s position.  The participant will be instructed to tap their foot 
as quickly as possible by lifting the ball of their foot off the platform and placing it back 
down.  They will be told that in order for a tap to count, their foot must clear the platform 
when lifting and make contact with the platform when descending.  There will be no 
further instructions as to how they should tap their foot, and the participant will be 
encouraged to tap in a way that they feel will allow them to produce the fastest speed.  
The participant will be instructed to keep their foot resting calmly on the force platform 
before and after the collection period in order to obtain a baseline EMG.  The participant 
will be allowed several brief practice trials of the tapping task before testing begins.  
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For all FTTs, force platform data will be collected at a sampling rate of 2,000 Hz 
and synchronized with the motion capture data, which will be collected at 200 Hz using 
Qualisys Oqus.  EMG data will also be synchronized with the force and motion capture 
data and collected at 2,000 Hz using Trigno’s recording system.   Foot tap speed will be 
evaluated 3 ways: 1) research assistant manually counting the number of times, based on 
observation and sound, that the foot makes contact with the ground, 2) force platform 
recording of GRF, and 3) motion capture cameras tracking the foot markers’ movements.   
10-s FTT: The first test will be the 10-s FTT, for which the participant will be 
instructed to tap their foot as quickly as possible for 10s.  The researcher who is running 
the computer will indicate when to begin and end tapping.  This FTT will be performed 3 
times, with a 60s break between each trial.  The average number of taps from the 3 trails 
of the 10-s test, as determined by the researcher through visual inspection of the GRF 
data, will be used to determine each person’s target speed for the 30%, 60%, and 100% 
trials that will follow. 
Next, the participant will perform three 10-s trials; 1 at 30%, 1 at 60%, and 1 at 
100% of maximal tapping speed.  These trials will be used to examine whether muscle 
recruitment patterns change at submaximal tapping speeds and if individuals’ ability to 
match a speed is impacted by age.  To achieve the desired pace, a metronome will be set 
at the appropriate cadence and the participant will be given 3, 4 s long trials at the speed 
being tested to practice.  Once the participant feels comfortable with the task, they will be 
given 30s to rest before the trials begin.  The participant will perform each 10-s trial 
while trying to match the metronome’s cadence.  The order of the 30, 60, and 100% trials 
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will be randomized between participants and blocked by group.  Sixty seconds of rest 
will be given between trials.  Each speed will be tested once.   
Preferred Gait Speed 
Participants will walk around 100m around a 20m loop at their preferred walking 
speed and data will be collected 3 times as they pass through the collection zone.  
Additional trials where the participant walk 10m, starting from a stop, will be given if the 
trial speeds are greater than 0.2 m/s different.  Both the preferred gait speed walk and the 
400m walk will occur in the same space which will consist of 2 cones located 20m apart 
on a 22m long raised runway.  The runway is 1.2m wide where the participant will be 
turning and a research assistant will be positioned to ensure the participant’s safety at all 
times.  The runway has a collection zone with 11 Qualysis motion capture cameras, and 
infrared timing gates which are 6m apart and are used to determine speed.  Motion 
capture, EMG, and time to complete 6m will be collected each time the participant is 
walking to the right through the collection zone.   
400m Walk 
After completion of the foot tap tests, the participant will have a 5 minute rest 
period.  An EMG electrode will be taped to the posterior heel of the shoe to determine 
timing of heel contact.  For the 400m walk test, the participant will be instructed to walk 
at a brisk pace that they believe they can maintain the entire time, or to walk as if they 
were walking to catch the bus.  The 400m walk will consist of 20 laps between two cones 
positioned 20m apart.  Before the 400m walk, the research assistant will explain the 
modified Borg Scale to the participant, which will be used to rate their perceived exertion 
before, every 100m during, and immediately after the 400m walk (3).  For this scale, a 
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“0” indicates an effort level of ‘nothing at all’ and “10” indicates an effort level of 
‘extremely strong’ or absolutely maximal. 
Following completion of all tests, the markers and electrodes will be removed 
from the participant and they will be given a $20 Visa gift card and the option to take 
booklets on PA for the aging adult.  Any remaining questions will be addressed, and they 
will be escorted to their car. 
The researchers will call the participants 3 and 6 months after their testing to ask 
if they have fallen, or had an unexpected contact with the ground, in the past 3 months, 
and if so, how many times. 
Data Analysis 
Physical function will be determined using the SPPB score and SPPB-A score.  
To determine the SPPB score (out of 12), each test (chair rise, walk time, and balance) 
will be scored from 0 to 4, with a 4 indicating no impairment for that task (Appendix).  
Not all of the tasks described will be used to determine the SPPB score.  All of the 
described physical function tasks will be used to determine the SPPB-A score, and a 
more comprehensive score will be given (Appendix).  Individual components of the 
physical function measures may also be used for exploratory analyses.  Force data 
collected during the side-by-side balance stand may be used to examine margin of 
stability.  Force data collected during the chair rise task may be used to examine 
distribution of pressure while standing to see if one leg is providing more of the force 
than the other. 
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The voluntary and stimulated measures during Visit 1 will provide information on 
central and peripheral muscle properties, such as peak torque, RFD, T1/2, CAR.  Peak 
torque will be determined for the MVC, twitch and tetanus.  The maximal RFD (Nm·s-1) 
will be defined as the peak dF/dt while the torque is rising and will be determined for the 
MVC, 40% of MVC contractions, twitch and tetanus (50Hz, 0.5ms) contraction.  Half 
relaxation time (T1/2, ms) will be determined from the tetanus and will be defined as the 
time it takes for the torque to fall 50% after the last stimulation.  The CAR will be 
determined from the superimposed tetanus during the MVC, with an increase in force 
during stimulation indicating a deficit in central activation.  A twitch will be administered 
at the end of the collection to determine if there was any potentiation from the trials.   
Data collected during the muscle strength tests on the Humac Norm will be: 
isometric plantar and dorsiflexion torque, and EMG activity during maximal contractions.  
The highest torque for plantar and dorsiflexion, identified using a MatLab program, from 
each set of 3 trials will be used to determine the participant’s MVC for each task.  The 
average rectified and integrated EMG signal for a 1-s window during maximal torque 
production from the highest MVC will be used as peak EMG (mV), which will be used 
for CoActM normalization.  
The FTTs will be analyzed using a Matlab program which will be written to 
analyze the force platform data and determine how many times the foot made contact 
with the platform based on a deviation of force from the baseline, and through this 
method, count the number of taps.  This Matlab program will also be used to quantify 
several dynamic variables that will capture tapping patterns.  These will include the ITI 
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(ms), as well as the average, standard deviation and coefficient of variation of the ITI, 
and the average, standard deviation, and coefficient of variation of the GRF.   
Visual 3D (C-Motion) will be used to track the motion of the markers during all 
FTTs, and each time the participant is walking to the right during the preferred gait and 
400m walk.  The heel accelerometer will be used to identify foot contact during both 
walking trials.  6Motion capture data collected during the FTTs and gait trials will be 
analyzed by a Matlab program that will use the angle of the ankle and the foot’s velocity 
to separate the motion into dorsiflexion and plantar flexion time segments.  With this 
information, the EMG data will be separated into dorsiflexion and plantar flexion time 
segments, and the agonist and antagonist activity for each period will be quantified to 
determine CoActM, while the onset and offset time of the muscles will be used to 
determine CoActT. 
The EMG data for visit 2 will be collected at a sampling rate of 2,000 Hz during 
the MVCs, foot tap tests, preferred gait, and 400m walk.  Data will be rectified and 
filtered with a Butterworth filter, then integrated to determine the amount of muscle 
activity.  The EMG data from the FTT, preferred gait, and 400m walk will be normalized 
to the maximal activity recorded when the muscle was acting as an agonist muscle during 
the MVC tests on the Humac Norm.  The normalized antagonist and agonist activity for 
each task will be used to determine CoActM based on Equation 1. 
Preferred and brisk gait speed (400m walk) will be determined using the timing 
gates 6m apart (m·s-1).   Walking speed will be quantified at each lap, or 10 times, during 
the 400m walk, to examine how the participant’s speed changes during the endurance 
walk.  The total time required to complete the 400m walk is will also be recorded.  If the 
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participant needs to rest during the study, which they will be encouraged not to do, the 
duration of time they rest will be recorded and added to the total walk time but will not be 
used in the calculation of 400m walk speed.  
Statistical Analyses 
Statistical Analysis Software, version 9.3 (SAS Institute Inc., Cary, NC) will be 
used for all statistical analyses (Table 11).  A p value of 0.05 will be used to establish 
significance for all analyses.  Differences between descriptive variables (age, height, 
body mass, BMI, BP, SPPB and SPPB-A score, PA counts and count intensity, 400m 
walk time, preferred and brisk gait speed, plantar and dorsiflexion MVC torque, maximal 
rate of torque development, T1/2, CAR, FES-I, fall occurrence at follow up) of the groups 
will be evaluated using Analysis of Variance (ANOVA). These variables may be used as 
covariates in the primary analyses if statistical difference is found.  To address the first 
aim, ANOVA tests will be used to determine whether there is a difference in FTS, 
CoActM, and CoActT during the 10s-FTT between the young, older, and older impaired 
groups.  A regression analysis will be applied to the CoActM and FTS data for all of the 
older adults, combined.  The second aim will be addressed through an ANOVA of 
CoActM during the first three laps of 400m walk in all 3 groups, and a linear correlation 
between CoActM and gait speed will be performed using the data for all older adults, 
combined.  The second aim also includes exploratory regression analyses of CoActM and 
gait speed variability during the 400m walk and FES-I score for all older adults, 
combined.  The final, exploratory aim will be addressed by analyses of the dynamic 
variables, such as ITI, GRF, toe excursion and number of foot taps during a 10s period, to 
examine foot tapping patterns during the 10s and 90s FTT.  This aim will also be 
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addressed by analyses of the dynamic variables during the constrained (30, 60 and 100% 
of maximal FTS) conditions.     
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Revisions from original proposal 
The aims of the study have been adjusted slightly based on the methods that were 
analyzed.  A subset of the data collected were analyzed and presented here in order to 
address a more cohesive question.  
Coactivation during the 400m walk and at preferred walking speed are not 
presented in this paper, but will be analyzed later.  The relationship between coactivation 
during gait and fear of falling are also not presented.  Additionally, data were collected 
while participants tapped to a metronome which was set at 30, 60 and 100% of the 
participant’s foot tap speed to address exploratory Aim 3.2.  These data are not included 
in this thesis but will be analyzed in the future to look at variability while tapping to a 
rhythm. 
The purpose of this study was to investigate the potential causes of slowed foot 
tap speed in older adults, determine whether mobility function is related to slowed 
tapping, and explore the relationship between foot tap speed and physical function in 
older adults.  The following hypotheses were tested (Figure 1A):  
Hypothesis 1. Greater performance variability during the FTT is related to slower 
foot tap speed 
1.1 Performance variability (COV-ITI) during the FTT will be greater in 
higher and lower functioning older adults than young adults  
1.2 COV-ITI will be negatively associated with FT count in older adults 
Hypothesis 2. Greater muscle coactivation during the FTT is related to slower foot 
tap speed 
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2.1 Muscle coactivation during the FTT will be greater in higher and lower 
functioning older adults than young adults 
2.2 Coactivation will be negatively associated with FTC in older adults 
Hypothesis 3. Slower contractile properties of the dorsiflexor muscles is related to 
slower foot tap speed. 
3.1 Young adults will have faster rates of force development and relaxation in 
the dorsiflexor muscles during the stimulated and voluntary submaximal 
contractions than both older groups 
3.2 The rate of force development in the dorsiflexor muscles will be positively 
correlated with FTC in both young and older adults 
3.3 The rate of force relaxation in the dorsiflexor muscles will be negatively 
correlated with FTC in both young and older adults 
Hypothesis 4. Foot tap speed will be related to usual walk speed, 400m walk speed, and 
SPPB-A, in older adults 
4.1 FTC will be positively associated with physical function in older adults 
4.2 COV-ITI will be negatively associated with physical function in older 
adults  
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CHAPTER 4 
EXPANDED MANUSCRIPT 
 
 
Introduction 
Beginning around the 7th decade of life, there are changes that occur within the 
neuromuscular system that can lead to a decline in physical function. Among other 
things, alteration in the neuromuscular system include changes in overall control of 
movement, muscle activation patterns, and muscle contractile speed.   
Rapid repetitive tapping tests, such as a 10s foot tapping test (FTT), have been 
used by neurologists to track changes in central nervous system (CNS) disease as 
individuals with diseases affecting the CNS are unable to perform rapid foot tapping as 
quickly as healthy individuals (14, 27, 51, 58, 59, 76).  The FTT has also been used in the 
study of neuromuscular function in aging (29, 59, 76).  Studies have shown that older 
adults are unable to perform rapid foot tapping as quickly as young adults (29, 59).  This 
slowing of foot tap speed holds true even when young and older adults have comparable 
muscle strength per unit mass (i.e specific strength), central control of rate of force 
development, and voluntary activation of their ankle dorsiflexor (DF) muscles (29).  The 
cause of slower foot tap speeds in older adults is still not known.   
Rapid tapping requires the rapid recruitment and relaxation of the muscles 
involved in the action.  Therefore, the speed of muscle activation can impact how quickly 
the task is performed.  Muscle contractile properties, such as the rates of force 
development and relaxation, can limit the overall speed of a movement during repetitive 
tasks.  Kent-Braun et al. found that older adults did not have a deficit in 
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voluntary:stimulated RFD, indicating no impairment in central conduction speed of the 
DF muscles during submaximal, rapid contractions; however, the older adults still had a 
slower foot tapping speed, a potential indicator of slowing within the CNS (29). Older 
adults have been shown to have slower RFD and RFR in the DF muscles than younger 
adults when elicited by a stimulated contraction (57).  The slowing of voluntary RFD and 
RFR of the DF have not been studied in conjunction with changes in rapid tapping 
performance.  Thus, it is unknown whether slowing of the DF muscle during voluntary 
contractions impairs foot tap speed. 
Poor control of repeated muscle activations could also limit the speed of rapid 
tapping, by means of increased coactivation and greater motor variability.  Coactivation 
is defined as activation of the antagonist muscle during agonist activation.  Greater 
muscle coactivation has been observed at faster movement speeds (23, 48).  Muscle 
coactivation of the lower extremities has been found to be greater in older than young 
adults but there are inconsistencies in the literature specifically regarding shank 
coactivation (22, 38, 53, 64, 66).  Some investigators have found that shank coactivation 
does not differ between old and young adults while walking (10, 64), or when performing 
isometric, concentric, or eccentric contractions (32), while others report greater shank 
coactivation during gait (22, 53, 66) and static standing (40, 53).  It remains unclear 
whether coactivation could be a cause of slowed repetitive tapping in older adults.   
A change in central motor drive could result in more variability in performance, 
and potentially contribute to the slowing of foot tapping speed.  One way to determine 
tapping variability is the coefficient of variation of the timing between taps (COV-ITI).  
Older adults have been shown to have greater COV-ITI during rapid finger tapping, and 
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in both young and older adults, variability in tapping increased when tapping frequency 
increased (71). However, a study by Tomita et al., examined performance variability 
while foot tapping at a fixed speed and found that COV-ITI was not correlated with foot 
tapping speed in healthy older adults, but was correlated in individuals who had had a 
stroke (76). While the FTT and variability were not tested simultaneously, the variability 
seen in stroke patients but not healthy individuals might suggest that greater variability in 
tapping performance could be indicative of poor motor control.  
Several functional tests have been validated for identifying older adults with 
declining physical function, including gait speed, 400m walk time, the Short Physical 
Performance Battery (SPPB), and the SPPB-A (15, 70, 72, 80).  Speed of rapid, repetitive 
foot-tapping has been linked to physical function in individuals with cervical myelopathy 
(59), but few studies have examined its relationship to function in older adults.  A 
longitudinal study of older women by Kent and colleagues (unpublished results) found 
that slower tapping speed at baseline predicted a decline in gait speed, and thus mobility, 
at a two year follow-up.  These results suggests that the slowing of foot tap speed may 
precede changes in physical function.   
The purpose of this study was to investigate the potential causes of slowed foot 
tap speed in older adults, determine whether mobility function exaggerates the causes of 
slowed tapping, and explore the relationship between foot tap speed and physical 
function in older adults.  The following hypotheses were tested (Figure 1A):  
Hypothesis 1. Greater performance variability during the FTT is related to slower 
foot tap speed 
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1.1 Performance variability (COV-ITI) during the FTT will be greater in 
higher and lower functioning older adults than young adults  
1.2 COV-ITI will be negatively associated with FT count in older adults 
Hypothesis 2. Greater muscle coactivation during the FTT is related to slower foot 
tap speed 
2.1 Muscle coactivation during the FTT will be greater in higher and lower 
functioning older adults than young adults 
2.2 Coactivation will be negatively associated with FTC in older adults 
Hypothesis 3. Slower contractile properties of the dorsiflexor muscles is related to 
slower foot tap speed. 
3.1 Both older adults will have a slower rate of force development and 
relaxation in the dorsiflexor muscles during the stimulated and voluntary 
submaximal contractions than Young adults 
3.2 The rate of force development in the dorsiflexor muscles will be positively 
correlated with FTC in both young and older adults 
3.3 The rate of force relaxation in the dorsiflexor muscles will be negatively 
correlated with FTC in both young and older adults 
Hypothesis 4. Foot tap speed will be related to usual walk speed, 400m walk speed, 
and SPPB-A, in older adults 
4.1 FTC will be positively associated with physical function in older adults 
4.2 COV-ITI will be negatively associated with physical function in older 
adults  
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Methods 
Study Design 
Participants were tested at two visits, with approximately one week between each 
visit.  The first visit included informed consent, anthropometrics, questionnaires, the 
SPPB and SPPB-A, usual walk tests, familiarization protocols, foot tapping tests on both 
legs, and stimulated and voluntary contractions to measure contractile properties of the 
DF of the slower leg.  The second visit consisted of electromyography (EMG) 
measurements of the tibialis anterior, medial and lateral gastrocnemius, and soleus 
muscles of the slower leg  during: DF and plantar flexion (PF) maximal voluntary 
isometric contractions (MVICs), foot tapping, and the 400m brisk walk; motion capture 
was record during the latter two tests.  A physical activity monitor was worn between the 
first and second visit to assess habitual activity behavior. 
 
Participant Characteristics 
Eighteen young (9F) and 28 older (14 F) healthy adults were recruited.  All 
participants were healthy, and self-reported as being free of any diseases that affected the 
central nervous system or blood flow.  All participates were nonsmokers and were not 
taking any medication that impacted muscle function.  Participants were sedentary to 
recreationally active.  Informed consent, approved by the Institutional Review Board at 
the University of Massachusetts Amherst, was obtained for all participants. 
Participants completed the Short Form-36 (SF-36), a short questionnaire which 
asks about physical and emotional health, and assesses whether the individual 
experiences general pain (81).  Participants also completed the Falls Efficacy Scale- 
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International (FES-I), which asks a series of questions about how concerned an individual 
is about falling in a variety of scenarios (83).  
 
Physical Activity (PA) 
Participants wore a uniaxial accelerometer (model GT1M, Actigraph, LLC 
Pensacola, FL., USA) on their right hip during all waking hours for 7 days.  Participants 
kept a log of their activity to enable detailed manual inspection of the accelerometry data.  
They were instructed to maintain as normal a PA pattern as possible.   A minimum of 5 
days with at least 10 hours of wear time each was needed for analysis, with one of the 5 
days being a weekend day.  Data was collected in 60s epochs and separated into time 
spent in low-intensity (1-1951 counts·min-1, ≤3 METS) and moderate-to-vigorous (≥1952 
counts·min-1, >3 METS) PA based on cutpoints established by Freedson et al. (11).  
Counts, minutes of moderate to vigorous physical activity (MVPA) per week, and percent 
of wear time in activity (minutes of light + MVPA divided by minutes of wear time, %) 
were determined.   
 
Physical Function 
Physical function was determined using the SPPB, SPPB-A, usual walking speed, 
and 400m brisk walking speed (15, 70).  The SPPB is a common functional test that 
scores individuals from 0-12 based on their ability to complete 3 tasks: time to complete 
a 4m walk at a preferred walking speed, ability to balance for 10s in 3 positions (tandem, 
semi-tandem, side-by-side stance), and time to complete 5 chair rises (15, 16).  The 
SPPB-A (appendix) is an expanded version of the SPPB, scored continuously from 0-4, 
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which allows for more precise scoring and distinguishes among relatively high 
functioning individuals who receive a 12, thus reducing the ceiling effect inherent to the 
SPPB (70).  The older adults were separated into higher (HFO) and lower (LFO) 
functioning groups based on their performance on the SPPB-A (70).  The median value 
for women, 2.47, and the median value for men, 2.59, were used to divide the older 
adults, by gender, into 2 groups.  Each group had 14 participants, 7 of which were 
women. 
Usual gait speed was determined during two 6m walks in the hallway, with the 
average speed during these 2 trials used for subsequent analysis. For the 400m walk, 2 
cones were set up 20m apart in the Biomechanics Lab.  Motion capture, force data, EMG 
and time were recorded in a 6m space approximately half way between the cones.  The 
400m walk consisted of 10 laps around the 2 cones, during which participants were 
instructed to walk at a brisk walking speed, and the verbal cue of “walk quickly as if you 
were trying to watch a bus” was given each lap.  Total time to complete the 400m walk 
was determined.  
  
Foot Tap Test  
For the FTT, the participants were seated in a standard chair about 15 cm behind a 
60 x 120 cm force platform (AMTI, Advanced Mechanical Technology Inc, Watertown 
MA, sampling rate 2,000 Hz).  The participants were seated comfortably with their hip 
and knee at approximately 90° of flexion, the middle and ball of their foot on the force 
platform, and their heel resting off the platform (Figure 2A and 1B).  Participants were 
positioned so that their shoe was not in contact with the force platform when the ball of 
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their foot was lifted. This placement produced distinct peaks for each tap during the FTT, 
as shown in Figure 2C. The participants were allowed several brief practice trials before 
testing began.  For each trial, the participants were instructed to tap their foot as quickly 
as possible for 10s.  
During the first visit, each participant performed the FTT on each leg at least two 
times, in a randomized, alternating order, and only force data was recorded.  The foot tap 
count (FTC) from the fastest trial of each leg was determined. The leg with the lower 
FTC, or rather the slower leg, was subsequently tested for contractile speed and EMG. 
During the second visit, the FTT was performed again on the slower leg and 
motion capture and EMG data were collected in addition to force data.  Retro-reflective 
markers were placed on the 1st and 5th metatarsal, medial and lateral malleolus, tibial 
tuberosity, 1st toe, along with a heel cluster (Figure 2A and B).  The collection area had 
11 Qualysis motion capture cameras (Qualisys, Gothenburg, Sweden) set to collect data 
at a sampling rate of 200 Hz.   
Force platform data from the FTT was analyzed with a MATLAB program that 
identified a tap as a local force maxima, calculated FTC as the sum of local maxima 
during the 10s trial, determined the timing between taps (intertap-interval, ITI) and 
calculated the variability of tap timing (COV-ITI) during the 10s trial (Figure 2C and 
Figure 3). 
 
EMG 
Wireless surface EMG electrodes (Trigno, Delsys Inc, Natick MA, USA) were 
placed on the belly of the tibilias anterior (TA), soleus (Sol), medial gastrocnemius (MG), 
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and lateral gastrocnemius (LG) muscles of the slower leg during the second visit 
following established guidelines (73).  Before being placed, the skin was shaved with a 
razor and cleaned with alcohol swabs.   
Maximal muscle activity for EMG normalization was achieved during DF and PF 
MVICs on a Humac Norm dynamometer.  Participants were positioned with their foot at 
10° of PF, their knee at approximately 160°, and their hip at approximately 170°.  
Participants completed three, 3-5s MVICs of PF with 90s of rest between trials.  Verbal 
encouragement was provided during each MVIC.  If two of the MVICs differed by more 
than 10%, the participant preformed a 4th MVIC.  The same protocol was used for the DF 
MVICs.  Electromyography was recorded for each muscle group during the MVICs, and 
the MVIC trial with the greatest peak torque was used for EMG normalization.   
The EMG signal was rectified, bandpass filtered between 20 Hz and 500 Hz, and 
normalized to the average EMG signal collected for 0.5 seconds during peak torque of 
the DF and PF MVICs. The muscle activation ratio (Act-R) during the FTT was 
calculated to examine the overall activation of the TA, or agonist, relative to the plantar 
flexor, or antagonist, muscles and is defined as:  
𝐴𝐴𝐴 − 𝑅 =  𝐼𝐼𝐴𝐼𝐼𝐼𝐼𝐴𝐼𝐼 𝑇𝐴 𝑁𝑜𝐼𝑟 𝐸𝐸𝐸 (% 𝑜𝑜max)
𝐴𝐴𝐼𝐼𝐼𝐼𝐼 𝐼𝐼𝐴𝐼𝐼𝐼𝐼𝐴𝐼𝐼 𝑁𝑜𝐼𝑟 𝐸𝐸𝐸 (% 𝑜𝑜 max)  𝑜𝑜 𝑆𝑜𝑆,𝐸𝐸, 𝐿𝐸 ∗ 1𝐹𝑇𝐹 
For the FTT, the normalized EMG signal for each muscle was integrated over the 10s of 
tapping, and normalized to the length of the test (10s) and the number of taps.  This 
yielded an integrated, normalized EMG value per tap for each muscle group which was 
used to calculate Act-R.  An Act-R value greater than one indicates greater relative 
activation of the tibialis anterior than the plantar flexor muscles.   
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Coactivation during the FTT was calculated by determining the correlation 
between the agonist and antagonist’s EMG signals. Correlation during the 10s of the FTT 
was calculated based on the agreement in timing and shape of the EMG signals for the 
TA and Sol, which were first normalized to the EMG during the MVIC.  The Sol was 
chosen for this analysis because it is the most active PF muscle when the knee is bent 
(69).  A value of 1 indicates that the EMG signals are identical and a value of 0 indicates 
no agreement in the timing and shape of the TA and Sol signal; thus greater coactivation 
was indicated by a correlation coefficient closer to 1.  Custom MATLAB codes were 
written to process and analyze the EMG data.  Specifically, EMG data was rectified, band 
pass filtered between 20-500 Hz, then normalized to EMG during the MVIC.  Data was 
then run through the Act-R algorithm and the EMG correlation analysis.  A time lag 
value was not calculated for the EMG correlation analysis measure.  The EMG data was 
corrupted for one HFO and they were excluded from EMG analysis. 
 
Contractile Speed 
Contractile speed of the TA muscle of the slower leg were examined using 
voluntary and stimulated contractions.  A stimulating electrode, attached to a stimulator 
(model DS7, Digitimer Stimulator, Hertfordshire, UK), was placed on the peroneal nerve, 
about 1 cm distal to the fibular head to stimulate the TA.  A gold-plated disk electrode 
(10 mm) was placed on the muscle belly of the TA, determined during maximal DF, to 
record the EMG, and another acted as a ground and was placed on the distal tendon of the 
TA.  A copper ground plate (6x6 cm) was placed half way between the stimulating and 
EMG electrode to reduce stimulation artifact.  The participant was supine with their hip 
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at ~120°, knee at ~40° of knee flexion, and ankle at 10° of plantar flexion.  Their foot 
was securely strapped to a custom designed platform attached to a force transducer which 
is used to measure DF force, and the knee was strapped down to reduce movement 
artifact.  All stimuli and EMG recordings were obtained using LabView software 
(National Instruments, Austin TX).  The stimulation intensity was determined through 
single twitch stimuli with increasing current until additional increases in current yield no 
increase in the compound muscle action potential.  A supramaximal current (115% of the 
current associated with the compound muscle action potential) was used for subsequent 
stimulations.   
Three baseline twitches were administered while the participant was relaxed and 
at least 30s rest was given between each of them.  The participant then performed 4 DF 
MVICs lasting 3-5s, with a one min rest between each trial.  During the last MVIC, a 
tetanic train (50 Hz, 0.50s) was administered when force had plateaued in order to 
calculate central-activation ratio (CAR).  Next, the participant performed voluntary rapid, 
submaximal isometric (ballistic) contractions as quickly as possible with the target of 30-
60% of peak MVIC force; a light diode box was used for visual feedback and verbal 
encouragement was given.  Participants performed 3 trials, each consisting of 3 rapid 
contractions, and trials with peak force outside of the range of 30-60% of peak MVIC 
force were excluded from analysis.  Thirty seconds of rest was given between trials. After 
a 1 min break, a tetanic train (50 Hz, 0.5s) and twitch stimulation were applied in quick 
succession while the participant remained fully relaxed.    
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The CAR was calculated as a rise in force when a tetanus stimulus was applied 
during a maximal voluntary contraction.  If force did not rise, the CAR was determined to 
be 1.  If force increased, the amount of central failure was calculated as: 
𝐹𝐴𝑅 =  𝑃𝐼𝐼𝑃 𝑠𝑠𝑠𝐼𝐼𝑠𝑟𝑠𝑜𝑠𝐼𝐼 𝑠𝐴𝑠𝑟𝑠𝑆𝐼𝐴𝐼𝐼 𝑜𝑜𝐼𝐴𝐼 (𝑁𝑟)
𝑃𝐼𝐼𝑃  𝐴𝑜𝑆𝑠𝐼𝐴𝐼𝐼𝑣 𝑜𝑜𝐼𝐴𝐼 (𝑁𝑟)  
Voluntary slope and Maximal Rate of Force Development (Max RFD) and 
Relaxation (Max RFR) were calculated for the ballistic contractions, and Stimulated Max 
RFD and RFR were calculated for the twitch contractions.  For all contraction types, Max 
RFD and RFR were calculated by first normalizing the force values to peak force of the 
contraction, then the greatest instantaneous rate of force development or relaxation was 
determined; in other words, Max RFD and RFR occurred when the second derivative 
crossed zero.  Slope of force development and relaxation were calculated for the ballistic 
contractions as the change in force and time from the start of force development to the 
peak force, or from peak force to the return of force to baseline.  Slope of force 
development and relaxation were not determined for the twitch contractions.  Figure 4 
illustrates the analysis of Slope and Max RFD from a ballistic contraction. 
Twitch contractions were used to examine twitch force and M-wave 
characteristics, or the muscle response to a single electrical stimulation.  In addition to 
Stimulated Max RFD and RFR, time to peak force and half relaxation time (T1/2) were 
calculated from twitch force.  The M-wave duration was calculated as the length of time 
the TA muscle took to transmit the action potential, or duration of the negative peak plus 
the positive peak.  The M-wave amplitude was calculated from the difference in mV 
between the negative and positive peak, while the M-wave negative peak was the 
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difference in mV between baseline and the negative peak.  Twitch and M-wave 
characteristics were calculated from the average of three twitch contractions.   
 
Statistics  
A one-way ANOVA was used to compare the three groups for Hypotheses 1.1, 
2.1, and 3.1. When significant main effects were found, Tukey’s post-hoc analysis was 
performed to identify differences between groups.  Data that were not normally 
distributed were tested with a Kruskal-Wallis test.  To address Hypotheses 1.2 and 2.2, 
regression analysis was performed between FTC and potential mediators of slowed foot 
tap speed in all of the older participants.  To address Hypothesis 3.2, regression analysis 
was performed between contractile speed and FTC in the young and older participants 
separately.  A regression analysis was performed in order to examine the relationship 
between FTC and COV-ITI and physical function in all of the older participants for 
Hypotheses 4.1 and 4.2.  Multiple regression analyses were used to determine which 
measures physical functions had the largest influence on FTC for the older participants. 
An alpha value of 0.05 was used to establish significance. 
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Results 
Participants   
Physical function and physical activity measures are summarized in Table 1.  The 
HFO group was younger than the LFO.  The SPPB-A differed across groups such that 
Young>HFO>LFO. For the SPPB, all Young scored a 12, eleven HFO scored a 12, and 
three HFO scored an 11.  The LFO had SPPB scores ranging from 8-12 with a median 
value of 11.  The three groups differed in usual walk speed, and post-hoc analysis 
revealed that LFO was slower than HFO and Young.  The 400m brisk walking speed 
differed across groups such that Young>HFO>LFO; one HFO was excluded from 
analysis because his 400m walk speed was greater than two standard deviations above the 
mean speed for the HFO.  For the SF-36, physical function, energy and fatigue, pain, and 
total score were examined and significant main effects between groups were found.  Post-
hoc analysis revealed that LFO scored worse than Young on the physical function 
questions.  For their energy and fatigue score, the HFO>LFO>Young, with a lower value 
indicating greater fatigue.  Post-hoc analysis of the pain scores indicated that LFO 
experienced greater pain, in general, than HFO.  The overall composite score for the SF-
36 was greater for HFO than LFO and Young.  The groups did not differ in BMI or FES-I 
score.   
On average, participants wore their physical activity monitors 14.3 hours per day 
(14.2±1.3 hrs for Young, 15.0± 1.1 for HFO, 13.8±1.0 for LFO), for 6.7 ±1.0 days.  
There was a significant main effect across groups for daily PA counts and MVPA; post 
hoc analyses indicated that LFO had fewer counts and both HFO and LFO had fewer 
minutes of MVPA than Young.  All three groups spent a comparable percentage of wear 
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time in activity. One HFO woman was excluded from PA analysis because she was 
greater than two standard deviations about the HFO’s mean for minutes of MVPA. She 
was not excluded from other calculations because she was not an outlier for any other 
metric. 
 
Foot Tap Variability  
Figure 3 shows examples of 10s of foot tap data from representative individuals in 
the Young (3A), HFO (3B) and LFO (3C) groups whose COV-ITI for the faster foot was 
close to the group mean.  Group data for the FTT are presented in Table 2.  For the faster 
foot, there were main effects for group for FTC and variability of tap timing (COV-ITI), 
with post hoc tests revealing slower tap speed in LFO compared with Young and HFO, 
and greater COV-ITI in Young than LFO (p<0.05).  There were no differences between 
groups in FTT variables for the slower foot (second visit).   
 
Muscle Activation 
Figure 5 shows sample EMG data from the four muscles during the FTT.  Muscle 
activation for each muscle during the FTT, relative to activation during the MVIC, 
showed a main effect between groups. Post-hoc analyses revealed that HFO and LFO had 
greater activation of their TA and MG than Young during the FTT, and HFO also had 
greater relative activation of the Sol and LG than Young (p<0.05, Table 3).  The groups 
did not differ in average Act-R during the FTT, but Young had a higher correlation 
coefficient than HFO during the FTT, indicating greater coactivation (p<0.05).  Figure 5, 
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panels B and C, show EMG data for a representative Young (5B) and HFO (5C) adults; 
participants whose correlation coefficients were close to the group means were selected.  
Maximum EMG signals were recorded during MVIC performed on the Humac 
Norm dynamometer.  There was a main effect for DF and PF force during the MVICs; 
post hoc analysis revealed that Young and HFO produced more force during DF trials 
than LFO, and Young produced greater PF force than LFO (p<0.05).  Specifically, the 
Young adults produced an average PF force of 75.8 ± 22.8 Nm and DF force of 37.6 ± 
10.3 Nm; HFO produced an average PF force of 56.4 ± 18.7 Nm and DF force of 36.7 ± 
11.4 Nm; and LFO produced an average PF force of 56.9 ± 27.1 Nm and DF force of 
26.8 ± 8.7 Nm. While MVIC force varied by group, the EMG amplitude during the 
MVICs, which were used for normalization, did not differ between the groups for any of 
the muscles (p>0.05).   
No participants in Young or HFO showed central activation failure, thus they 
were able to fully activate their TA muscle; CAR values were 1.00 ± 0.00 for Young 
(n=14) and HFO (n=14).  Two individuals in LFO had central activation failure, with 
CAR values of 0.90 and 0.92; the overall group average for LFO was 0.99±0.04 (n=12).  
Peak MVC torque recorded on the DF apparatus did not differ between groups and was 
43.4 ± 11.7 (n=18), 35.8 ± 9.1 (n=13), and 35.2 ± 7.0 Nm (n=14) for Young, HFO, and 
LFO respectively.   
 
Contractile Speed 
For the voluntary ballistic contractions, the only measure that differed between 
groups was the slope of force development, with post-hoc analysis revealing that Young 
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had a faster slope of force development than LFO (Table 4).  Force produced during these 
contractions did not differ across groups.  
Twitch and M-wave characteristics are reported for a subset of participants due to 
difficulties during data collection, Table 5.  Peak twitch force and time to peak force were 
the only twitch characteristics that differed between groups.  Post-hoc analyses revealed 
that HFO had a lower peak twitch force than Young, and that LFO had a longer time to 
peak force than Young (p<0.05).  There were significant differences between the groups 
for the M-wave properties.  Post-hoc analyses revealed that Young had a greater M-wave 
amplitude than HFO and LFO, and a greater M-wave negative peak than HFO (p<0.05).   
Twitch and M-wave data were excluded if stimulation was not done (n=2), or if 
twitch force was less than Nm (n =11).  One HFO male was excluded from the 
calculations of voluntary and stimulated contractile speeds.  The data from this 
participant were greater than 2 standard deviations above the mean DF force, slope of 
force development and relaxation for the HFO group.  However, these data are included 
for all other analyses because the FTC for each leg and each of the functional measures 
were less than two standard deviations above the average for the HFO group.  One 
possible explanation for the higher DF force and faster contractile speeds in this 
individual is that he is a drummer, an activity that trains the DF muscles.  
 
Associations between Foot Tap Characteristics and Potential Moderators 
Associations between FTC and variability of tapping (COV-ITI), coactivation, 
and muscle contractile speed were examined for the older participants and data are 
presented in Table 6.  The FTC of the faster leg was not correlated with COV-ITI during 
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the same trial (p=0.517, r2=0.016), nor was FTC of the slower leg correlated with COV-
ITI in the older participants (Table 6).   
Within the older participants, there was not an association between FTC and 
muscle activation, Act-R, for the same trial (Figure 6A).  Foot tap count and the 
correlation coefficient during the same FTT were negatively associated (r2=0.273, 
p=0.005) in the older participants (Figure 6B).  The Act-R and correlation coefficient 
were not related in the older participants (r2=0.061, p=0.214). 
There was no significant relationship between FTC and slope of force 
development and relaxation during the ballistic contraction for the older participants 
(Figure 7 B and D).  However, there was a relationship between FTC and Max RFD and 
RFR in the older participants (Figure 8 B and C).  Foot Tap Count and MVIC force were 
not associated in the older participants (p=0.387).  The Young adults’ FTC was strongly 
associated with slopes of force development (r2=0.523, p <0.001) and relaxation 
(r2=0.394, p<0.005) during the ballistic contractions, as seen in Figure 7 A and C.  The 
Young adults’ FTC was also positively associated with Max RFD (r2=0.245, p=0.037, 
Figure 8A) and with MVIC force (r2=0.476, p=0.001). 
Associations between Foot Tap Count and physical function in the older 
participants were examined and results are presented in Table 7.  Foot tap count from the 
faster leg was positively correlated with SPPB-A score (r2=0.329, p=0.001, Figure 9A), , 
and MVPA (r2=0.182, p=0.023, Figure 9C) in the older participants.  Foot tap count of 
the faster leg was not correlated with 400m brisk (p=0.176, Figure 9B) or usual walking 
speed (p=0.094).  Foot tap count from the faster leg was negatively correlated with age 
for the older participants (r2=0.277, p=0.004, Figure 9D).  Foot tap count of the slower 
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leg from visit 2 was positively correlated with MVPA (r2=0.158, p=0.036), but not with 
SPPB-A (p=0.084), usual walk speed (p=0.633), 400m walk speed (p=0.108), or age 
(p=0.441) in the older participants.  
The COV-ITI of the faster foot was not associated with any measures of physical 
function or age (Table 8).  The COV-ITI of the slower foot was positively associated with 
SPPB-A score (r2=0.181, p=0.024) and usual walking speed (r2=0.202, p=0.017), but not 
with 400m walk speed (p=0.212), MVPA (p=0.887) or age (0.248).  
A step-wise multiple regression analysis of the impact of age + SPPB-A score on 
FTC of the faster foot was significant (r2=0.413, p=0.0013), but only SPPB-A contributed 
significantly to this association (p=0.024).  A multiple regression analysis was also run to 
examine the impact of age, SPPB-A score, MVPA, and 400m walk speed on FTC of the 
faster foot.  The regression was significant (r2=0.482, p=0.0034) with all four variables, 
but only SPPB-A contributed significantly (p=0.023).    
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Discussion 
The main purpose of this study was to determine whether increased performance 
variability (COV-ITI), greater muscle coactivation, or slower muscle contractile 
properties are associated with slowed foot tap speed in older adults (Figure 1A).  Overall, 
lower FTC in older adults was related to greater muscle coactivation, determined by 
correlation analysis of the EMG signals, and slower Max RFD and Max RFR.  However, 
FTC was not related to COV-ITI in older adults (Figure 1B).  Higher FTC was associated 
with faster voluntary contractile speeds in Young adults (Figure 1C). The secondary 
purpose was to determine if FTC and COV-ITI were related to physical function in older 
adults.  The data showed that FTC of the faster foot was related to SPPB-A score, a 
composite measure of physical function, in older adults.  Contrary to what was 
hypothesized, the COV-ITI of the FTT on the slower leg was positively associated with 
SPPB-A and usual walking speed, with a lower COV-ITI related to worse physical 
function.  
 
Foot Tap Variability 
Hypothesis 1.1 was not supported by the data, as Young adults had a greater 
COV-ITI than LFO, but COV-ITI did not differ between Young and HFO.  The COV-ITI 
was not related to FTC in the fastest trial from either the faster or the slower foot in older 
adults.  This result suggests that variability in performance of the FTT does not limit foot-
tapping speed in older adults.  This result is not in agreement with findings from other 
studies which found greater variability with age, but those studies were examining 
variability while tapping to a set metronome speed (71, 76).  The FTT does not supply a 
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rhythm for participants to match but rather allows participants to employ whatever 
tapping method yields the best results, and greater tapping variability did not negatively 
affect performance for this metric.   
A smaller COV-ITI score in the LFO group could indicate a more diseased state 
as a reduction in movement variability has been associated with diseased states (18).  
Findings from our study support the idea that there is reduced variability in a diseased 
state as COV-ITI of the slower foot was positively related to SPPB-A and usual walking 
speed.  These data suggest that those with lower physical function tended to have less 
variability while tapping their slower foot.  Thus a smaller COV-ITI during the FTT 
could indicate a movement impairment that is not seen in healthy older adults.   
 
Muscle Activation 
Muscle coactivation was hypothesized to be greater and to negatively affect foot 
tap speed in older adults.  Overall, muscle activation was greater in HFO than Young for 
each muscle, and greater in LFO than Young for the TA and MG muscles.  To calculate 
muscle activation, EMG data during the FTT were normalized to muscle activation 
during MVICs.  The Act-R, a ratio indicating the relative magnitude of DF:PF muscle 
activation during the whole 10s trial, did not differ between the groups.  The Act-R was 
normalized to the number of taps to remove the possibility of a bias based on FTC. The 
HFO had the closest Act-R value to one, indicating that their PF muscles were more 
active relative to their TA muscle; one possible explanation for the greater relative PF 
activity is that HFO had greater PF activation between each tap, potentially helping the 
foot return to the ground.  Figure 5 helps to visually support this hypothesis, showing a 
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HFO individual with PF activity between each TA burst and an Act-R of 1.24 (5C).  The 
EMG data in Figure 5B shows a Young adult who had smaller PF activity between taps 
and an Act-R of 2.21, indicating greater DF activation relative to PF activation.  The Act-
R per tap does not indicate how much the TA and PF muscle activity overlapped, but a 
correlation analysis does. 
Here, EMG correlation analysis indicated how much the timing of the TA and Sol 
signals were in agreement during the FTT; a larger correlation coefficient indicates 
greater coactivation.  Relative to EMG collected during an MVIC, the Sol was the most 
active PF muscle during the FTT (Table 3).  Previous studies have also shown that the 
Sol is more active during rapid DF tasks than the MG and LG (23), and that the Sol is 
relatively more active when the knee is bent than straight (69).  Because of this, the Sol’s 
EMG activity was selected for the correlation analysis with the TA.  A correlation 
coefficient of 1 indicates that the muscles were active at the same time with the same 
relative shape, while a value closer to 0 indicates that the EMG signals did not align. It 
was hypothesized that a smaller correlation coefficient would be more beneficial during 
the FTT because it would indicate that the muscle groups were not opposing each other, 
or rather, coactivation was less.   
Young adults were hypothesized to have less coactivation than HFO and LFO, 
and in older adults, greater coactivation was hypothesized to be associated with a lower 
FTC.  The data do not fully support this hypothesis.  Young had a greater correlation 
coefficient than HFO, but there was no difference in the correlation coefficient between 
Young and LFO.  In the older adults, there was a negative association between the 
correlation coefficient and FTC (Figure 6B).  It appears that it is more advantageous in 
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older adults to have a smaller amount of coactivation, or overlap in TA and Sol activity 
during the FTT, consistent with the original hypothesis.  However, in Young adults, 
greater coactivation was not associated with a lower FTC.  It is possible that the Young 
adults had compensatory mechanisms to deal with the greater coactivation, such as 
producing a greater amount of DF force on each tap.  In Young adults, coactivation 
appears to play a minimal role in determining FTC, while muscle properties like strength 
and speed have a stronger association with FTC. 
Notably, there was PF activity between the foot taps in some individuals, 
suggesting that some individuals are employing a tapping strategy where the foot is being 
actively returned to the ground (Figure 5C).  It is possible that those with a lower 
correlation coefficient are activating the PF muscles to return the foot to the ground 
during the FTT, and those with a higher correlation coefficient are activating their PF 
throughout the FTT to stabilize their foot.  Interestingly, there was not a relationship 
between Act-R and the correlation coefficient in a given trial in older adults, suggesting 
that the older adults are employing varying muscle activation patterns to tap as fast as 
possible.  Overall, the negative association between FTC and the correlation coefficient 
supports the hypothesis that greater coactivation limits FTC in older adults. 
 
Contractile Speed  
The third hypothesis addressed the relationship between contractile speed of the 
DF muscles and FTC in the slower leg in young and older adults during voluntary 
ballistic contractions and stimulated twitch contractions.  Ballistic contractions with the 
target of ~40% MVIC force have been used previously in the literature to quantify the 
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maximum voluntary RFD (29).  Ballistic contractions of the DF were chosen for this 
study because they mimic the contractions necessary for the FTT; both are submaximal 
tasks that require rapid activation and deactivation of the DF muscles and modulation of 
motor unit recruitment.  However, one major difference is that the ballistic contractions 
are singular and isometric while the FTT employs dynamic, repeated contractions 
through a limited range of motion.   
During the voluntary ballistic contractions, the only difference between the 
groups was that Young adults had a greater slope of force development than the LFO.  
For the stimulated twitch contractions presented on a subset of participants, Young adults 
had a faster time to peak force than LFO, and Max RFD was approaching significance 
between the groups (Table 5). Time to peak twitch force is dependent on peak force and 
is not necessarily indicative of contraction speed.  However, Young and LFO had similar 
peak twitch forces and LFO had a slower time to peak; therefore, slower time to peak 
does indicate slowing of stimulated force development in LFO.   
The LFO had slower rates of force development during both their voluntary and 
stimulated contractions when compared with the Young adults, indicating slowing of 
force development in their DF muscles.  The LFO also had a lower FTC than Young.  
These relationships were not seen in HFO, suggesting that greater mobility impairments 
may be related to slowed DF force development speed and FTC.  Kent-Braun et al. did 
not see an impairment in central rate of force development during ballistic contractions in 
older adults but did see a difference in FTC (29).  One possible reason for the difference 
between the results of this thesis and Kent-Braun’s study is that they were expressing 
RFD as a measure of central function and normalized the voluntary RFD to the 
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stimulated RFD, which was not done here.  It has been suggested that the FTT can be 
used as a measure of central function (29, 59), partially because slowing is seen in 
diseases affecting the CNS; however, this thesis did not compare FTC to other measures 
of central function, like central RFD. 
In the older adults, FTC of the slower leg was correlated with the Max RFD and 
Max RFR during the ballistic contractions, but not with the slopes of force development 
and relaxation.  This suggests that the maximum, instantaneous rate at which the muscle 
is able to contract and relax is related to foot tap speed in older adults, but not the speed 
of the overall movement.  It is possible that the FTT, a dynamic repetitive task, and the 
ballistic contractions, a single isometric contraction, were eliciting different responses in 
the DF muscles of the older adults.   This difference in contraction type could potentially 
explain why Max RFD and RFR were related to FTC in older adults but the slope of the 
full ballistic contraction was not.  
Moderate correlations between FTC and slope of force development and 
relaxation were observed in Young adults.  The Max RFD was also positively correlated 
with FTC in the Young adults.  These relationships suggest that contractile speed during 
voluntary contractions controls how quickly young adults can perform the FTT.  
Differences in muscle contractile speed appear to explain a large amount of the variations 
in FTC in the younger adults. 
The Young adults produced greater force during maximal DF and PF than LFO.  
Peak torque production was correlated with performance on the FTT in the young adults 
but not the older adults, indicating that strength impacts FTT performance in young 
adults but not older adults.  Tomita et al. suggested that one of the advantages of the FTT 
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is that participants are not instructed to go through their full range of motion while 
tapping and are only instructed to go as fast as possible (76).  By removing the restriction 
of using the full range of motion, the FTT may be able to reduce the impact strength has 
on performance in older adults.  This hypothesis is supported by the observation that FTC 
and strength were not associated in the older participants.  Future studies should examine 
the foot’s excursion during the FTT to determine what percent of the range of motion is 
employed and whether this impacts FTC.  Toe excursion was measured for the FTT, 
though the data are not presented. 
The M-wave characteristics of the muscle were also determined during the twitch 
stimulation, however, it is hard to draw conclusions about the muscle properties from this 
data.  The M-wave is the EMG response to a single stimulation and generally indicates 
the excitability of the muscle (57).  However, M-wave amplitude and duration will vary 
based on adiposity and distance between electrodes, making it difficult to compare 
between individuals (57, 79).  Our results suggest that HFO had reduced excitability of 
the TA muscle compared to Young, but this could be due, in part, to the smaller twitch 
force response in HFO than Young. 
 
Foot Tap Test and Physical Function 
The Young and HFO had a faster FTC than LFO, indicating an impairment in foot 
tapping speed with age and mobility function.  In the older adults, the FTC of the faster 
foot was positively associated with SPPB-A score, providing support to hypothesis 4.  
Based on the finding that FTC of the slower foot was only related to MVPA, it appears 
that FTC of the faster foot is a better predictor of physical function in older adults.  It is 
possible that the older adults in this study were healthy enough that any reductions in 
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function of the slower leg, such as reduced DF during swing phase, could be 
compensated for by the faster leg during measures of physical function.   
The COV-ITI of the slower foot during the FTT was positively correlated with 
SPPB-A and usual walking speed in the older adults, but the COV-ITI of the faster foot 
was not.  It was hypothesized that greater variability would be indicative of worse 
function, but the data does not support this hypothesis.  Rather, our results suggested that 
a lower COV-ITI could be indicative of a diseased state (18). 
Notably, FTC of the faster foot was related to physical function while COV-ITI of 
the slower foot was related to physical function in the other adults.  This study measured 
the FTC on both legs because FTC of the faster, dominate foot is typically reported in the 
literature but mobility could be restricted by the more impaired limb (29, 59, 76).  This 
study was not aimed at comparing the two legs but rather was aimed at understanding 
why a slowing of foot tapping speed might occur.  Future studies may address the 
differences in the faster and slower leg and explore the relationship between function and 
asymmetry during the FTT. 
 
Physical Function 
The older adults in this study were healthy with minimal limitations to their 
physical function.  All of the older participants had a usual walking speed above 0.8 m·s-
1, which has been proposed as a threshold for identifying individuals with mobility 
impairments (72).  Another common measure of physical function is the SPPB.  The 
older adults in this study scored between an 8-12 on the SPPB.  A score of 12 on the 
SPPB indicates no functional impairment, and a score between 8-10 indicates mild to 
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moderate impairment in older adults (15).  The SPPB-A was used to separate the older 
adults because it reduces the ceiling effect of the SPPB and is a more sensitive measure 
of function (70).  To the best of our knowledge, there are no set criteria for dividing older 
adults based on the SPPB-A.  The original paper by Simonsick et al. reported a mode 
range of 2.33- 2.66 on the SPPB-A for women and a mode range of 2.66-3 for men (70).  
The median value for the older women in our study, 2.47, was within the range reported 
by Simonsick, and the median value for the older men in our study, 2.59, was slightly 
below the range reported by Simonsick (70).  The FTC was sensitive enough to 
distinguish between Young and LFO and was related to a composite measure of physical 
function in the healthy older cohort. One advantage of the FTT over usual walking speed 
and SPPB is that individuals with limited mobility can perform it.  However, in a study of 
healthy older adults, by itself, the FTT is not indicative of current mobility function. 
The participants in this study were moderately active.  The HFO and Young group 
did not differ in counts, but Young had a greater amount of MVPA than HFO and LFO.  
The percent wear time spent in activity was comparable across groups, suggesting that 
the older adults remained active but at a lower intensity than the young adults. On 
average, the older adults in both groups were meeting PA guidelines of 150 minutes of 
MVPA a week (1).  The FTC and MVPA were related in the older adults, suggesting 
speed of rapid repetitive activation is maintained with physical activity. Although the 
older adults in this study were active, their physical function was still reduced compared 
to the young adults and reduced function was correlated with foot tapping speed.  
According to the SF-36, Young adults scored the lowest in the energy/fatigue 
category, contributing to their lower SF-36 score than HFO.  When compared to 
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normative values for the SF-36, Young scored slightly below their age’s mean for energy, 
LFO scored slightly above their age’s mean, and HFO were considerably above the mean 
for their age (4).   All three groups scored higher than their age’s mean for pain and 
physical function, contributing to the idea that this is a healthy group of individuals.  The 
HFO had a higher overall composite score of the SF-36 than LFO, due in part to the 
HFO’s higher scores on energy/fatigue, pain, and physical function.  Overall, the quality 
of life in HFO was higher than LFO based on the results of the SF-36.  Notably, there 
was no difference in FES-I score between groups, indicating that the groups had 
comparable fears of falling.   
The relationship between FTC and physical function in young adults was not 
examined in this study, primarily because the Young adults were not expected to have 
any functional impairments.  The FTT can indicate changes in function, but it is unlikely 
that it is related to function in young adults who have a greater number of compensatory 
mechanisms than older adults. Likewise, the associations between FTC and potential 
moderators of speed were not studied in Young and old combined.   
 
Limitations 
A limitation of this study was that the participants were relatively active and 
healthy.  Participants were, on average, meeting physical activity guidelines of >150 min 
of MVPA a week.  The Young adults were also more active than LFO and HFO, making 
it harder to remove the impact of aging on function.  The older adults in this study were 
relatively healthy, with all participants having a gait speed greater than 0.8 m·s-1 and an 
SPPB ≥8.  Having older adults who were frailer have led to different results, such as a 
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larger range in function.  This study was also a cross-sectional, making it impossible to 
test if the FTT can predict future mobility impairments in older adults.  This also limits 
the exploration of causal relationships between FTC and potential moderators of slow 
speed. 
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Conclusion 
Overall, greater muscle coactivation during the FTT and slowed force 
development in the DF muscles negatively affects the speed with which older adults can 
perform rapid repetitive foot tapping.  Foot tap speed, particularly of the faster foot, and 
foot tap variability, particularly of the slower foot, is related to physical function in 
healthy to mildly mobility-impaired older adults.  In young adults, the largest limiting 
factors for rapid repetitive foot tapping is the contractile speed and strength of the DF 
muscles. 
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CHAPTER 5 
SUMMARY 
 
With age, many changes occur within the neuromuscular system which can 
negatively affect muscle and mobility function.  Among other things, with age there is 
slowed activation and deactivation of the dorsiflexor muscle.  However, the dorsiflexor 
muscles typically are less affected by declines in physical activity associated with aging 
compared with other muscle groups, such as the knee extensors and plantar flexors.  
Slowed activation and deactivation of the dorsiflexor muscles with age is evident during 
rapid tapping tasks, such as the Foot Tap Test (FTT).  The FTT is an easy, potentially 
useful tool for monitoring changes in dorsiflexion function in older adults. This study 
suggests that declines in foot tap speed with age could be caused by greater muscle 
coactivation during the FTT and reduced rate of force development of the dorsiflexor 
muscles. Declines in the speed of dorsiflexor activation becomes vitally important in 
individuals with large mobility impairments; specifically because impaired dorsiflexion 
during gait can increase the risk of falling.  The FTT is potentially better at tracking 
functional changes in a population with mobility impairment and reduced dorsiflexor 
function. However, even among the healthy older adults in this study, slower foot tap 
speed was related to reduced physical function, which shows promise for predicting 
future changes in mobility function (28).  Simple tests to measure mobility function, like 
the FTT and gait speed, may aid clinicians in tracking the mobility of their patients and 
identifying individuals at risk of future mobility impairments.  The FTT could also aid in 
identifying individuals in need of training interventions to prevent or delay the onset of 
mobility impairment.  
 
 
74 
 
Table 1. Participant Characteristics 
 
 
 
Young 
(n=18) 
HFO 
(n=14) 
LFO 
(n=14) 
p value, 
main 
effect 
Age, years 25.0 (3.1) 70.9 (3.1) * 76.0 (5.0)* ǂ <0.001 
BMI, kg/m2 23.1 (2.6) 24.4 (3.8) 25.4 (2.6) 0.101 
Physical Function     
SPPB-A 3.11 (0.35) 2.78 (0.15) * 2.24 (0.28) *ǂ <0.001 
Usual walk speed, 6m, m·s-1 1.46 (0.28) 1.40 (0.16) 1.11 (0.14)* ǂ <0.001 
400m brisk walk speed, m·s-1 1.92 (0.16) 1.68 (0.15) * 1.53 (0.11) *ǂ <0.001 
FES-I 17.1 (1.8) 18.1 (3.1) 18.9 (2.2) 0.097 
SF-36, sum 656.2 (81.8) 740.3 (48.2) * 667.1 (76.2) ǂ <0.001 
SF-36, physical function 
score 
98.9 (2.1) 95.4 (5.7)  89.6 (6.9) * <0.001 
SF-36, Energy/fatigue score 56.9 (13.2) 85.0 (8.8) * 67.9 (13.4) *ǂ <0.001 
SF-36, Pain score 90.6 (16.6) 94.3 (6.5) 82.5 (13.3) ǂ 0.031 
Physical Activity     
PA counts/1000·day-1 295.8 (99.3) 241.9 (127.0) 187.5 (46.8)* 0.011 
MVPA, min per week 
301.4 
(108.8) 
173.4 (140.6)* 173.2 (84.8)* 0.002 
% of wear time in activity 29.7 (7.3) 33.7 (8.2) 29.3 (7.5) 0.265 
 
Participant characteristics for Young, Higher Functioning Older (HFO) and Lower 
Functioning Older (LFO) adults.  Number of participants per group indicated as (n).  
Values are mean ±SD; * different than young, ǂ different than HFO.  Body Mass Index 
(BMI) and Fall Efficacy Scale-International (FES-I) did not differ between groups.  
Physical Activity (PA) and minutes of Moderate to Vigorous Physical Activity (MVPA) 
were greater in Young than LFO.  The Short Form-36 (SF-36) asked about overall health 
of the participants and included specific questions for fatigue and pain.  
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Table 2: Outcomes of the Foot Tap Test (FTT) of the Faster and Slower Foot  
 Young 
(n=18) 
HFO 
(n=14) 
LFO 
(n=14) 
p value, 
main effect 
FTT faster foot     
Count 54.4 (7.5) 53.1 (5.7) 45.9 (7.0) *ǂ 0.003 
ITI, ms 0.187 (0.022) 0.190 (0.022) 0.223 (0.035) * ǂ <0.001 
COV-ITI, % 20.5 (8.1) 18.7 (7.6) 12.3 (5.9) * 0.009 
FTT slower foot     
Count 51.3 (8.0) 48.3 (7.3) 44.9 (6.8) 0.063 
ITI, ms 0.200 (0.031) 0.212 (0.033) 0.229 (0.036) 0.060 
COV-ITI, % 19.8 (8.6) 20.7 (7.6) 16.4 (6.6) 0.310 
 
Data collected on Young, Higher Functioning Older (HFO) and Lower Functioning Older 
(LFO) adults during the FTT, including the intertap-interval (ITI) and coefficient of 
variability of the ITI (COV-ITI).  Foot tap data from the slower foot were collected on 
the second visit, simultaneously with EMG and motion capture data.  Number of 
participants per group indicated as (n).  Values are mean ±SD; * different than young ǂ 
different than HFO.    
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Table 3. Electromyography (EMG) data during the Foot Tap Test from the Slower 
Foot 
 
 Young 
(n=18) 
HFO 
(n=13) 
LFO 
(n=14) 
p value, 
main 
effect 
TA EMG, %·tap-1 0.444 (0.186) 0.655 (0.173) * 0.700 (0.238) * 0.002 
Sol EMG, %·tap-1 0.380 (0.190) 0.856 (0.600) * 0.625 (0.376) 0.008 
MG EMG, %·tap-1 0.129 (0.096) 0.302 (0.165) * 0.307 (0.218) * 0.004 
LG EMG, %·tap-1 0.255 (0.144) 0.597 (0.350) * 0.449 (0.299) 0.004 
Activation-ratio 1.92 (0.69) 1.45 (1.04) 1.94 (1.10) 0.307 
Correlation 
coefficient 
0.568 (0.209) 0.321 (0.129) * 0.437 (0.159) 0.001 
 
Electromyography (EMG) collected during the Foot Tap Test for the tibialis anterior 
(TA), soleus (Sol), medial gastrocnemius (MG) and lateral gastrocnemius (LG) muscles 
in Young, Higher Functioning Older (HFO) and Lower Functioning Older (LFO) adults.  
The EMG data is normalized to EMG activity during a maximal voluntary contraction 
and to the number of foot taps.  Number of participants per group indicated as (n).  
Values are means ±SD; * different than young ǂ different than HFO.  Tukey’s PostHoc 
run to test for significance.   
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Table 4. Voluntary Contractile Speed of the Slower Foot during Ballistic 
Contractions 
 
 Young 
(n=18) 
HFO 
(n=13) 
LFO 
(n=14) 
p value, 
main 
effect 
Force, % MVIC 44.3 (6.0) 46.9 (6.26) 44.8 (5.8) 0.461 
Slope of force 
development, Nm·ms-1 
0.137 (0.039) 0.117 (0.035) 0.098 (0.031) * 0.013 
Slope of force 
relaxation, Nm·ms-1 
0.115 (0.040) 0.112 (0.039) 0.093 (0.043) 0.259 
Max RFD,  
%peak force·s-1 
1.080 (0.190) 1.037 (0.174) 0.998 (0.139) 0.412 
Max RFR,  
%peak force·s-1 
-1.004 (0.170) -1.012 (0.188) -0.961 (0.218) 0.753 
 
Dorsiflexor contractile speed collected during voluntary ballistic contractions to ~45% of 
Maximal Voluntary Isometric Contractile (MVIC) force in Young, Higher Functioning 
Older (HFO) and Lower Functioning Older (LFO) adults.  The dorsiflexor muscles were 
tested for contractile properties, including Slope of force development and relaxation, and 
Maximal Rate of Force Development (Max RFD) and Relaxation (Max RFR).  Number 
of participants per group indicated as (n).  Values are means ±SD; * different than young 
ǂ different than HFO.  Tukey’s PostHoc run to test for significance.    
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Table 5. Dorsiflexion Contractile Characteristics of Slower Leg during Stimulated 
Twitch Contractions 
 
 Young 
(n=13) 
HFO 
(n=12) 
LFO 
(n=6) 
p value, 
main 
effect 
M-wave amp, peak to peak, 
mV 
9.20 (1.43) 7.19 (2.21) * 6.90 (1.18) * 0.009 
M-wave duration, ms 38.5 (3.2) 34.4 (5.2) * 38.4 (2.1) ǂ 0.046 
M-wave negative peak, mV 5.31 (0.94) 3.97 (1.28) * 4.13 (0.69) 0.009 
Peak Twitch force, Nm 2.76 (0.77) 1.95 (0.73) * 2.61 (0.39) 0.021 
Max RFD, %peak·s-1 2.26 (0.31) 2.33 (0.47) 1.88 (0.25) 0.056 
Max RFR, %peak·s-1 -1.11 (0.25) -1.18 (0.53) -0.85 (0.11) 0.225 
Time to peak force, ms 93.5 (11.3) 99.7 (16.2) 111.8 (15.1) * 0.045 
T1/2, ms 71.9 (16.8) 84.0 (31.1) 95.2 (7.8) 0.115 
 
Twitch and M-wave data from a subset of participants in the Young, Higher Functioning 
Older (HFO) and Lower Functioning Older (LFO) groups.  Twitch contractile 
characteristics include maximal rate of force development (Max RFD) and relaxation 
(Max RFR), time to peak force, and time until half relaxation (T1/2). Number of 
participants per group indicated as (n).  Values are means ±SD; * different than young ǂ 
different than HFO.  Tukey’s PostHoc run to test for significance. 
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Table 6. Regression Analyses for Potential Moderators of Foot Tap Count (FTC) of 
the Slower Leg in Young and Older Adults 
 
  FTC in older adults 
 
FTC in young adults 
 
r2 p value 
 
r2 p value 
Foot Tap Variability      
COV-ITI slower foot 0.001 0.855 
 
0.024 0.541 
Muscle coactivation      
Act-R 0.024 0.442    
Correlation coefficient 0.274 0.005  0.087 0.236 
Ballistic contractions      
% MVIC force 0.090 0.128 
 
0.024 0.540 
Slope of force development 0.117 0.081 
 
0.523 0.001 
Slope of force relaxation 0.135 0.059 
 
0.394 0.005 
Max RFD 0.345 0.001 
 
0.245 0.037 
Max RFR 0.162 0.038 
 
0.032 0.476 
MVIC force, N·m-1 0.173 0.387  0.476 0.002 
  
Foot Tap Count and COV-ITI for the same trial was compared for and slower foot in 
older adults.  Coactivation was determine based on the correlation coefficient and relative 
muscle activation was determined by the activation ratio (Act-R).  Foot Tap Count was 
also compared with force of ballistic contractions, which were ~ 45% of peak Maximal 
Voluntary Isometric Contraction (MVIC) force.  Foot tap count was compared with 
dorsiflexor contractile properties, including Slope of force development and relaxation, 
and maximal rate of force development (Max RFD) and relaxation (Max RFR).  Bolded 
lines indicate regressions with p<0.05.    
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Table 7. Regression Analyses for Foot Tap Count (FTC) and Measures of Physical 
Function in Older Adults 
 
 
FTC of faster foot vs 
function in older adults  
FTC of slower foot vs 
function in older adults 
 
r2 p value 
 
r2 p value 
SPPB-A 0.329 0.001 
 
0.111 0.084 
Usual walking speed 0.104 0.094 
 
0.009 0.633 
400m walking speed 0.072 0.176 
 
0.096 0.108 
MVPA 0.158 0.040 
 
0.143 0.065 
PA counts 0.211 0.014  0.117 0.075 
age 0.277 0.004 
 
0.023 0.441 
 
 
  
 
 
 
Foot Tap Count from the faster and slower feet (visit 2) in older adults compared with 
measures of physical function.  Functional measures included the advance Short Physical 
Performance Battery (SPPB-A), usual walking speed, 400m walking speed, minutes of 
Moderate to Vigorous Physical Activity (MVPA) a week, and age.  Bolded lines indicate 
regressions with p<0.05.   
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Table 8: Regression Analyses for Variability of the Intertap Interval (COV-ITI) 
during the Foot Tap Test and Measures of Physical Function in Older Adults 
 
 
COV-ITI of faster foot vs 
function in older adults  
COV-ITI of slower foot vs 
function in older adults 
 
r2 p value 
 
r2 p value 
SPPB-A 0.077 0.153  0.181 0.024 
Usual walking speed 0.110 0.084  0.202 0.017 
400m walking speed 0.001 0.894  0.029 0.212 
MVPA 0.166 0.035  0.001 0.861 
PA counts 0.036 0.334  0.011 0.590 
age 0.002 0.815  0.051 0.248 
 
 
  
 
 
 
Variability of tapping (COV-ITI) during the Foot Tap Test from the faster and slower feet 
(visit 2) in older adults compared with measures of physical function.  Functional 
measures included the advance Short Physical Performance Battery (SPPB-A), usual 
walking speed, 400m walking speed, minutes of Moderate to Vigorous Physical Activity 
(MVPA) a week, and age.  Bolded lines indicate regressions with p<0.05.   
 
  
 
 
82 
 
 
Figure 1. Summary of Primary Hypotheses and Results 
A 
 
 
B  
  
 
C 
 
A) Summary schematic of the hypotheses for older adults.  Solid arrows indicate a 
hypothesized moderator of Foot Tap Count (FTC) and the dotted arrow indicates a 
predictive relationship between FTC and function.  The numbers in each figure indicate 
the corresponding hypothesis. B) Summary schematic of the results in older adults.  C) 
Summary schematic of the results in young adults. Thicker lines in panels B and C 
indicate supported hypotheses. X indicates unsupported hypothesis.   
 
 
83 
 
Figure 2. Experimental Arrangement for the Foot Tap Test and Sample Force 
Output 
 
  
 
A) Placement of foot for the FTT. Participants were seated so the ball of the foot was on 
the force platform and the heel was off the force platform; retroreflective markers were 
place on specific anatomical locations to track foot movement; B) Retroreflective 
markers viewed in Qualysis; the arrow represents the net ground reaction force applied to 
the force platform; C) Sample force tracing from the FTT; local maxima are identified 
with a circle.  
A) B) C) 
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Figure 3.  Examples of Force Platform Fata from the Foot Tap Test 
 
 
 
 
 
 
 
An example of foot tap data recorded on the force platform from A) Young, B) Higher 
functioning older, and C) Lower functioning older adults.  A larger coefficient of 
variation of the intertap-interval (COV-ITI) indicates greater variability in foot tap 
timing.  Examples were selected to be close to each group’s average COV-ITI.    
A) COV-ITI = 20.9% 
B) COV-ITI = 19.3% 
C) COV-ITI = 13.3% 
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Figure 4: Example of Voluntary Ballistic Contraction and Calculation of Slope and 
Maximum Rate of Force Development (Max RFD) 
 
An example voluntary ballistic dorsiflexion contraction is shown in gray.  The Max RFD, 
shown here by a black dot, is the greatest instantaneous change in force.  The slope of 
force development, shown here as a dotted line, was calculated as the change in force 
from baseline divided by the change in time from the beginning of the force rise above 
baseline to peak force.   
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Figure 5: Examples of Normalized Electromyography (EMG) Signal during the 
Foot Tap Test (FTT) 
 
 
 
A) Example of normalized EMG for each muscle during 10s of rapid foot tapping. B) 
Example of normalized EMG for 1s of foot tapping in a Young adult; activation ratio 
(Act-R) = 2.21, correlation coefficient = 0.59. C) Example of normalized EMG for 1s of 
foot tapping in a HFO adult; Act-R = 1.24, correlation coefficient = 0.30.  For each 
muscle, the EMG data during the FTT were normalized to EMG data during a maximal 
voluntary isometric contraction.   
B) Normalized EMG for 1s of FTT from Young 
C) Normalized EMG for 1s of FTT from HFO 
A) Normalized EMG for 10s of FTT 
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Figure 6. Activation, Coactivation and Foot Tap Count in Older Adults 
 
 
 
Electromyography (EMG) data were collected during the Foot Tap Test for the slower 
foot at Visit 2.  Data are presented from the fastest trial on Visit 2.  A) Foot Tap Count 
was not related to the Coact-R.  B) Foot Tap Count was negatively related with the 
correlation coefficient (TA:Sol) in older adults. Higher functioning older adults are 
indicated by red circles and lower functioning older adults indicated by blue triangles.  
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Figure 7. Foot Tap Counts and Voluntary Slope of Force Development and 
Relaxation of the Dorsiflexor Muscles during Ballistic Contractions in Young and 
Older Adults 
 
 
 
Foot Tap Count vs slope of force development during ballistic contractions of slower foot 
in A) young, and B) older adults.  Foot Tap Count vs slope of force relaxation during 
ballistic contractions of slower foot in C) young, and D) older adults. Higher functioning 
older adults indicated by red circles and lower functioning older adults indicated by blue 
triangles.   
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Figure 8. Foot Tap Counts and Voluntary Maximum Rate of Force Development 
and Relaxation (Max RFD and RFR) of the Dorsiflexor Muscles during Ballistic 
Contractions in Young and Older Adults 
  
  
Foot Tap Count vs maximum rate of force development (Max RFD) during ballistic 
contractions of slower foot in A) young, and B) older adults.  Foot Tap Count vs 
maximum rate of force relaxation (Max RFR) during ballistic contractions of slower foot 
in C) young, and D) older adults. Higher functioning older adults indicated by red circles 
and lower functioning older adults indicated by blue triangles.   
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Figure 9: Correlations between Foot Tap Count (FTC) of the Faster Foot and 
Function in Older Adults 
 
 
  
 
Associations in older adults between FTC and A) advanced Short Physical Performance 
Battery (SPPB-A), B) 400m brisk walk speed, C) minutes of Moderate-to-Vigorous 
Physical Activity a week (MVPA), D) age.  Higher functioning older adults are indicated 
by red circles and lower functioning older adults indicated by blue triangles.  
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Table 9: Habituation Session Schedule  
Activity Time 
(min) 
Data collected 
Informed consent, Medical 
history form, FES-I, Par-Q, SF-36 
15 FES-I score 
Resting BP, height and body mass 5  BP, height, body mass, BMI 
PA monitor explanation 5  PA log, PA activity for 7 days 
Physical Function measures 15 SPPB and SPPB-A score, force 
platform data from balance tests and 
chair rise 
Familiarization: MVC, foot tap 20 FTS for each leg; testing leg 
determined 
Stimulation 20 Torque (voluntary and 
stimulated),CAR, RFD, T1/2 
Total time ~80  
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Table 10: Testing Session Schedule 
 
Activity Time (min) Data collected 
 
Warm up cycling and stretching 7 None 
EMG electrode placement and 
signal check 
 
10 None 
MVCs: plantar and dorsiflexion  20  EMG for TA, GM, GL, SO; torque 
for MVCs 
Motion capture markers placement 
and standing calibration, FTTs 
explained 
 
7  Standing calibration 
10 s foot tap test x3 10 # taps from the counter, GRF, 
motion capture, EMG 
 
30, 60 and 100% trials 10  # taps from the counter, GRF, 
motion capture, EMG 
 
100m walk- preferred gait speed 5 motion capture, EMG, speed (3 
times each) 
400 m walk- brisk walk 10  motion capture, EMG, speed (10 
times each) 
   
Total time ~80  
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Table 11: Summary of statistical analyses and hypothesis testing 
 
Hypothesis Primary Variables Groups Statistic 
 
1.1 FTS Young, older, older 
impaired 
 
ANOVA 
1.2 CoActM (FTT) Young, older, older 
impaired 
 
ANOVA 
1.3 CoActT (FTT) Young, older, older 
impaired 
 
ANOVA 
1.4 CoActM (FTT) 
FTS 
 
All older Linear regression 
2.1 CoActM (400m walk) Young, older, older 
impaired 
 
ANOVA 
2.2 CoActM (400m walk) 
Gait speed 
All older Linear correlation 
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APPENDIX B 
 ADDITIONAL FIGURE 
95 Figure 10. Set up of Foot Tap Tests 
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Figure 10: Set up of Foot Tap Tests 
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99 Physical Activity Readiness Questionnaire 
100 Falls Efficacy Scale-International  
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105 Short Physical Performance Battery (SPPB) scoring chart 
106 Advanced Short Physical Performance Battery (SPPB-A) scoring chart 
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Medical History Form 
Please fill out and sign in ink. This record is confidential. 
 
Medical History 
Do you take any prescribed or over-the-counter medications? Please include vitamins, 
herbs, or other dietary supplements. If yes please list the dose, frequency and the duration 
of use. 
________________________________________________________________________
________________________________________________________________________ 
 
Have you ever been told by a physician that you should not exercise? 
Yes ____ No ____ If yes, please explain: 
________________________________________________________________________
________________________________________________________________________ 
 
Do you have or have you EVER had any of the following problems? Check if YES and 
provide details below. 
____ Heart disease/rheumatic fever  ____ Thyroid disorder ____Asthma 
____ High blood pressure    ____ Claustrophobia  ____Allergies 
____ Elevated Cholesterol              ____ Anemia   ____Stroke 
____ Epilepsy or seizure disorder    ____Diabetes   ____Dizziness 
____ Blurred or double vision 
____ Orthopedic or joint problems (e.g., arthritis) 
____ Shortness of breath or difficulty in breathing 
____ Phlebitis, blood-clots, varicose veins, peripheral vascular disease   
 
Lifestyle 
Do you smoke cigarettes?   Yes ____ No ____ 
Do you drink alcohol?    Yes ____ No ____ 
Do you get regular exercise?    Yes ____ No ____ 
      If yes, number of times per week ________ 
Have you had surgery?    Yes ____ No ____ 
      If yes, when was this? _________________ 
 
Is there any other information or concerns you have that you feel we should know about 
before you participate in the study? If yes please explain.   
________________________________________________________________________
________________________________________________________________________ 
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Physical Activity Readiness Questionnaire 
  
 
1. Has a doctor ever said you have a heart condition and recommended only medically 
supervised activity? 
 
  YES_______  NO_______ 
 
2. Do you have chest pain brought on by physical activity? 
 
  YES_______  NO_______ 
 
3. Have you developed chest pain in the last month? 
 
  YES_______  NO_______ 
 
4. Do you tend to lose consciousness or fall over as a result of dizziness? 
 
  YES_______  NO_______ 
 
5. Do you have a bone or joint that could be aggravated by the proposed physical activity? 
 
  YES_______  NO_______ 
 
6. Has a doctor ever recommended medication for your blood pressure or a heart 
condition? 
 
  YES_______  NO_______ 
 
7. Are you aware through your own experience, or a doctor’s advice, of any other physical 
reason against your exercising without medical supervision? 
 
  YES_______  NO_______ 
 
Note:  If you have a temporary illness, such as a common cold, or are not feeling well at this 
time – POSTPONE. 
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Falls Efficacy Scale-International 
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Short Form-36 
 
Medical Outcomes Study:  36-Item 
Short Form Survey Instrument 
RAND 36-Item Health Survey 1.0 Questionnaire Items 
1. In general, would you say your health is: 
Excellent 1 
Very good 2 
Good 3 
Fair 4 
Poor 5 
 
2. Compared to one year ago, how would you rate your health in general 
now? 
Much better now than one year ago 1 
Somewhat better now than one year ago 2 
About the same 3 
Somewhat worse now than one year ago 4 
Much worse now than one year ago 5 
 
The following items are about activities you might do during a typical day. 
Does your health now limit you in these activities? If so, how much? 
(Circle One Number on Each Line) 
 Yes, Limited 
a Lot 
Yes, 
Limited a 
Little 
No, Not 
limited at 
All 
3. Vigorous activities, such as running, lifting heavy 
objects, participating in strenuous sports 
[1] 
 
[2] [3] 
4. Moderate activities, such as moving a table, 
pushing a vacuum cleaner, bowling, or playing golf 
[1] 
 
[2] [3] 
5. Lifting or carrying groceries [1] [2] [3] 
6. Climbing several flights of stairs [1] [2] [3] 
7. Climbing one flight of stairs [1] [2] [3] 
8. Bending, kneeling, or stooping [1] [2] [3] 
9. Walking more than a mile [1] [2] [3] 
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 Yes, Limited 
a Lot 
Yes, 
Limited a 
Little 
No, Not 
limited at 
All 
10. Walking several blocks [1] [2] [3] 
11. Walking one block [1] [2] [3] 
12. Bathing or dressing yourself [1] [2] [3] 
During the past 4 weeks, have you had any of the following problems with 
your work or other regular daily activities as a result of your physical 
health? 
(Circle One Number on Each Line) 
 Yes No 
13. Cut down the amount of time you spent on work or other activities 1 2 
14. Accomplished less than you would like 1 2 
15. Were limited in the kind of work or other activities 1 2 
16. Had difficulty performing the work or other activities (for example, it took 
extra effort) 
1 2 
 
During the past 4 weeks, have you had any of the following problems with 
your work or other regular daily activities as a result of any emotional 
problems (such as feeling depressed or anxious)? 
(Circle One Number on Each Line) 
 Yes No 
17. Cut down the amount of time you spent on work or other activities  2 
18. Accomplished less than you would like 1 2 
19. Didn't do work or other activities as carefully as usual 1 2 
 
20. During the past 4 weeks, to what extent has your physical health or 
emotional problems interfered with your normal social activities with 
family, friends, neighbors, or groups?  (Circle One Number) 
Not at all  1 
Slightly  2 
Moderately 3 
Quite a bit  4 
Extremely  5 
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21. How much bodily pain have you had during the past 4 weeks? (Circle 
One Number) 
None   1 
Very mild  2 
Mild   3 
Moderate  4 
Severe  5 
Very severe  6 
 
22. During the past 4 weeks, how much did pain interfere with your normal 
work (including both work outside the home and housework)? (Circle One 
Number) 
Not at all  1 
A little bit  2 
Moderately  3 
Quite a bit  4 
Extremely  5 
 
These questions are about how you feel and how things have been with 
you during the past 4 weeks. For each question, please give the one answer 
that comes closest to the way you have been feeling. 
How much of the time during the past 4 weeks . . . 
(Circle One Number on Each Line) 
 All of the 
Time 
Most of 
the Time 
A Good Bit 
of the Time 
Some of 
the Time 
A Little of 
the Time 
None of 
the Time 
23. Did you feel full of pep? 1 2 3 4 5 6 
24. Have you been a very 
nervous person? 
1 2 3 4 5 6 
25. Have you felt so down in 
the dumps that nothing could 
cheer you up? 
1 2 3 4 5 6 
26. Have you felt calm and 
peaceful? 
1 2 3 4 5 6 
27. Did you have a lot of 
energy? 
1 2 3 4 5 6 
28. Have you felt 
downhearted and blue? 
1 2 3 4 5 6 
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29. Did you feel worn out? 1 2 3 4 5 6 
 All of the 
Time 
Most of 
the Time 
A Good Bit 
of the Time 
Some of 
the Time 
A Little of 
the Time 
None of 
the Time 
30. Have you been a happy 
person? 
1 2 3 4 5 6 
31. Did you feel tired? 1 2 3 4 5 6 
 
32. During the past 4 weeks, how much of the time has your physical 
health or emotional problems interfered with your social activities (like 
visiting with friends, relatives, etc.)?  (Circle One Number) 
All of the time 1 
Most of the time 2 
Some of the time 3 
A little of the time 4 
None of the time 5 
 
How TRUE or FALSE is each of the following statements for you. 
(Circle One Number on Each Line) 
 Definitely 
True 
Mostly 
True 
Don't 
Know 
Mostly 
False 
Definitely 
False 
33. I seem to get sick a little easier 
than other people 
1 2 3 4 5 
34. I am as healthy as anybody I 
know 
1 2 3 4 5 
35. I expect my health to get worse 1 2 3 4 5 
36. My health is excellent 1 2 3 4 5 
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Short Physical Performance Battery (SPPB) scoring chart 
 
 4 3 2 1 0 
Walk Time (s) < 4.82  4.82-6.20  6.21-8.70 >8.70 Unable to 
complete 
Chair Rise 
Time (s) 
<11.1 11.2-13.6 13.7-16.6 >16.7 Unable to 
complete 
Balance Tests:      
Side-by-side 
(s) 
Not needed Not needed Not needed 10 0-9; tried but 
unable; not 
attempted 
Semi-tandem 
(s) 
10 10 10 0-9; tried but 
unable; not 
attempted 
<10; Tried 
but unable; 
not attempted 
Full Tandem 
(s) 
10 3-9 0-2; tried but 
unable; not 
attempted 
Not needed Not needed 
*For the balance test, if an individual is able to hold the semi-tandem pose for 10s they 
will not be tested in the side-by-side position, which is considered easier.  If an individual 
is unable to hold the semi-tandem pose for 10s, they will not be tested in the full tandem 
position because it is considered more difficult. 
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Advanced Short Physical Performance Battery (SPPB-A) scoring chart 
 
6m walk (casual speed; s):   1) __________ 2)__________ 
6m balance walk (casual speed, s): 1) __________ # times stepped outside 
________ 
     2) __________ # times stepped outside 
________ 
Timed 5x Chair rise (s):  ________   (split time)  Force file name 
______________ 
Timed 10x Chair rise (s): ________ 
Balance Side-by-Side Semi-Tandem Tandem One-leg 
Time (s)     
Force File     
 
Leg selected   R   L 
 
Scoring for Advanced Short Physical Performance Battery 
 
1. Total Advanced Balance Test Score ( 0 – 1) 
       (Semi-tandem+ tandem + one leg time)/90s) 
 
       .                   points 
2. Normalized Gait Speed  
       (4m/time)/(2 m/s) 
 
       .                   points 
3. Normalized Balance Gait Speed  
       (4m/time)/(2 m/s) 
 
       .                   points 
3. Repeated chair stand ratio score 
       (10 stands/ time to complete) 
 
       .                   points 
4. Total Advanced SPPB Score         .                   points 
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APPENDIX D 
 ADDITIONAL MEASURES COLLECTED 
 
Data were collected for the following measures but were not analyzed for this thesis 
• Force platform data during 30s balance tests 
o Feet side-by-side, semi-tandem, tandem, single leg stance 
o No motion capture or EMG data 
• Learning effect or repeatability of FTT from visit 1 to visit 2 
• Asymettry of the two feet during the FTT on visit 1 
• Speed, EMG, and motion capture of slower leg during preferred walking speed 
trials and during 400m walk 
o Analysis has been completed on the 400m walk but was not completed 
with enough time to add it to this paper 
• Foot tap data for 30, 60, 100% of max FTT speed.  Individuals were instructed to 
match the metronome speed while performing the task 
o Intertap-interval and coefficient of variation of the intertap-interval 
• Toe excursion during the Foot Tap Test 
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